{"gene":"ERO1A","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":2000,"finding":"Human ERO1-L (ERO1A) is a type II integral membrane protein of the endoplasmic reticulum that favors disulfide bond formation in secretory proteins; it complements the yeast ero1-1 thermosensitive mutant, and its activity requires conserved cysteines Cys-394 and Cys-397 (mutation of either abolishes function).","method":"Yeast complementation assay, subcellular fractionation (microsome), Endo-H glycan sensitivity, site-directed mutagenesis of conserved cysteines","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (yeast complementation, biochemical fractionation, mutagenesis) in a single study; foundational characterization paper","pmids":["10671517"],"is_preprint":false},{"year":2004,"finding":"Two conserved cysteine triads in human Ero1α (Cys85-Cys94-Cys99 and Cys391-Cys394-Cys397) cooperate in electron transfer; Cys94 likely forms the mixed disulfide with PDI; dominant-negative phenotypes arise from mutations in Cys394, Cys397, or Cys99; Ero1α forms mixed disulfides with both PDI and ERp44.","method":"Yeast complementation, site-directed mutagenesis, mixed-disulfide trapping with PDI and ERp44, redox-dependent conformational analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution-level mutagenesis combined with multiple functional readouts (yeast complementation, mammalian oxidative folding, mixed-disulfide trapping)","pmids":["15136577"],"is_preprint":false},{"year":2006,"finding":"Ero1α (and Ero1β) are dynamically retained in the ER via covalent interactions with ERp44 and non-covalent interactions with PDI; PDI and ERp44 compete for Ero1 binding; PDI also prevents Ero1 aggregation/dimerization, chaperoning its own oxidase; retention is KDEL/RDEL-dependent.","method":"Co-expression/secretion assay in HeLa cells, co-immunoprecipitation, dominant-negative PDI mutants lacking active-site cysteines","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction mapping with multiple mutants and two distinct ER-retention proteins, single lab","pmids":["16677073"],"is_preprint":false},{"year":2007,"finding":"Ero1-Lα is required for secretion of high-molecular-weight adiponectin complexes from adipocytes; siRNA knockdown of Ero1-Lα reduces adiponectin secretion, and ectopic Ero1-Lα expression in Ero1-Lα-deficient fibroblasts stimulates adiponectin secretion after adipogenic conversion.","method":"siRNA knockdown, ectopic overexpression in Ero1-Lα-deficient cells, adiponectin secretion ELISA, adipocyte differentiation model (3T3-L1)","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function experiments with defined secretory readout, single lab","pmids":["17452443"],"is_preprint":false},{"year":2008,"finding":"A disulfide switch regulates Ero1α activity: formation of a disulfide between active-site Cys94 (normally paired with Cys99) and regulatory Cys131 silences the enzyme; PDI (reduced) competes with Cys131 for Cys94, creating a feedback loop linking Ero1α activation to availability of its substrate reduced PDI. The isoform Ero1β lacks an equivalent switch.","method":"Mass spectrometry identification of regulatory disulfide, cell-based ER oxidation assay, Ero1α-C131A overexpression, comparison with Ero1β","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — MS-identified regulatory disulfide plus functional cell-based validation and isoform comparison in one rigorous study","pmids":["18833192"],"is_preprint":false},{"year":2008,"finding":"In Drosophila, Ero1L is specifically required for disulfide bond formation in the three Lin12-Notch repeats (LNRs) of the Notch extracellular domain; loss of Ero1L causes Notch accumulation in the ER, ER stress, and specific defects in lateral inhibition and inductive signaling.","method":"Mosaic genetic screen, biochemical disulfide bond assay of LNR domains, immunofluorescence of Notch localization, UPR reporter assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic screen plus biochemical substrate identification plus in vivo functional phenotypes, multiple orthogonal methods","pmids":["18809725"],"is_preprint":false},{"year":2008,"finding":"Recombinant human Ero1α has oxidase activity toward thioredoxin and PDI (requiring glutathione for sustained PDI oxidation); non-catalytic regulatory disulfides have a midpoint reduction potential of approximately −275 mV, making them stable in ER redox conditions and only partially reducible by PDI (E°' ≈ −180 mV), limiting excessive Ero1α activity.","method":"In vitro oxidase assay with recombinant Ero1α, site-directed mutagenesis of regulatory cysteines, redox potential measurement","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with recombinant enzyme, mutagenesis, and thermodynamic measurements in one study","pmids":["18971943"],"is_preprint":false},{"year":2009,"finding":"CHOP transcriptionally induces Ero1α during ER stress; Ero1α then stimulates the inositol 1,4,5-trisphosphate receptor (IP3R1) to increase IP3-induced calcium release (IICR), promoting calcium-dependent apoptosis. siRNA knockdown of Ero1α or IP3R1 blocks ER stress–induced apoptosis; reconstitution of Ero1α in Chop−/− macrophages restores IICR and apoptosis.","method":"siRNA knockdown (Ero1α, IP3R1), genetic loss-of-function (Ero1a, Chop mouse mutants), ectopic reconstitution in Chop−/− macrophages, live-cell calcium imaging, in vivo tunicamycin model","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (KO, siRNA, reconstitution), in vitro and in vivo validation, replicated across multiple cell types","pmids":["19752026"],"is_preprint":false},{"year":2005,"finding":"Ero1-Lα is transcriptionally induced by hypoxia and hypoglycemia via the HIF-1 transcription factor (independently of p53); siRNA-mediated reduction of Ero1-Lα inhibits VEGF secretion under hypoxia, implicating it as the key adaptive oxidoreductase for disulfide-dependent protein secretion under low-oxygen conditions.","method":"HIF-1 genetic epistasis (HIF-1-deficient cells), siRNA knockdown, VEGF secretion assay, diamide rescue experiment, northern/western blotting under hypoxia","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with HIF-1–deficient cells plus siRNA functional readout, two orthogonal approaches in one study","pmids":["15592500"],"is_preprint":false},{"year":2010,"finding":"Crystal structures of human Ero1α in hyperactive and inactive forms reveal that regulatory cysteines are positioned in a flexible loop; disulfide rearrangements within this loop modulate oxidative activity. Specific targeting of PDI is mediated by electrostatic and hydrophobic interactions between the Ero1α protruding β-hairpin and the PDI b'-domain substrate-binding pocket.","method":"X-ray crystallography of human Ero1α in two redox states, structural analysis of PDI-interaction interface","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures in two functional states providing atomic-level mechanistic detail","pmids":["20834232"],"is_preprint":false},{"year":2010,"finding":"Ero1α is almost exclusively localized to the mitochondria-associated ER membrane (MAM); this localization requires oxidizing ER conditions. Chemical reduction of the ER—but not ER stress per se—releases Ero1α from the MAM; normoxic conditions are also required.","method":"Subcellular fractionation, confocal immunofluorescence, chemical reduction of ER (DTT), hypoxia experiments","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct fractionation and live-cell imaging with pharmacological manipulation, single lab","pmids":["20186508"],"is_preprint":false},{"year":2010,"finding":"Ero1α oxidase activity generates H2O2 within the ER lumen in live cells; manipulation of Ero1-Lα levels by overexpression or siRNA causes parallel changes in luminal H2O2. Calcium mobilization from intracellular stores decreases ER H2O2, indicating crosstalk between ER redox and calcium signaling.","method":"Live-cell ER-targeted fluorescent H2O2 sensor, Ero1-Lα overexpression and siRNA, calcium mobilization experiments","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — first direct measurement of ER H2O2 in live cells with gain- and loss-of-function validation, novel approach","pmids":["20095866"],"is_preprint":false},{"year":2010,"finding":"The Ero1α-PDI redox cycle regulates retro-translocation of cholera toxin CTA1: reduced PDI binds and unfolds CTA1, then Ero1α oxidizes PDI to enable toxin release. Ero1α knockdown increases reduced PDI, blocks toxin release, and increases PDI–Derlin-1 interaction; Ero1α overexpression also blocks retro-translocation by preventing PDI engagement of the toxin.","method":"siRNA knockdown, Ero1α overexpression, retro-translocation assay, co-immunoprecipitation of PDI–Derlin-1","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional manipulation (KD and OE) with mechanistic co-IP readout, single lab","pmids":["20130085"],"is_preprint":false},{"year":2010,"finding":"Ero1α is expressed on blood platelets in association with PDI and αIIbβ3; it is recruited to the platelet surface upon agonist stimulation. Surface Ero1α physically associates with PDI and αIIbβ3 (confirmed by co-immunoprecipitation and confocal colocalization). Blocking surface Ero1α with antibodies decreases platelet aggregation and fibrinogen/PAC-1 binding; Ero1α transfection into MEG01 cells increases αIIbβ3 receptor activity.","method":"Co-immunoprecipitation, confocal microscopy, antibody-blocking platelet aggregation assay, PAC-1/fibrinogen binding, Ero1α transfection in MEG01 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal IP plus functional blocking antibody experiments plus overexpression, single lab","pmids":["20562109"],"is_preprint":false},{"year":2010,"finding":"Wild-type Ero1α oxidizes only one PDI active site at a slow rate; a deregulated Ero1α mutant lacking regulatory disulfides oxidizes both PDI active sites equivalently and faster. When PDI active-site cysteines are mutated to lower their reduction potential, wild-type Ero1α oxidizes both sites with a 12-fold increase in rate, demonstrating that PDI reduction potential limits the rate of Ero1α-catalyzed PDI oxidation.","method":"Novel dual active-site PDI redox assay, site-directed mutagenesis of Ero1α regulatory cysteines and PDI active sites, in vitro oxidation kinetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis of both enzymes and quantitative kinetic measurements","pmids":["20657012"],"is_preprint":false},{"year":2010,"finding":"After reductive challenge, ER disulfide content recovers within seconds; PDI is the main substrate of Ero1α; Ero1α mixed-disulfide complexes form primarily with PDI and to a lesser extent ERp57 and ERp72, but not with TMX3. PDI oxidation level is precisely regulated, not through ER import/export of thiols but via dynamic equilibrium between Ero1α and glutathione disulfide-mediated oxidation.","method":"Kinetics of ER redox recovery (ERO1-deficient cells), mixed-disulfide trapping, redox western blotting of PDI family members, thiol transport experiments","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ERO1-KO cells, disulfide trapping, transport assays) with replicated findings","pmids":["20802462"],"is_preprint":false},{"year":2011,"finding":"Ero1α is enriched in MAM and regulates Ca2+ fluxes at the ER-mitochondria interface: Ero1α knockdown inhibits mitochondrial Ca2+ fluxes; overexpression of redox-active Ero1α increases passive Ca2+ efflux from the ER, lowering ER Ca2+ content and mitochondrial Ca2+ responses to IP3 agonists.","method":"RNA interference, Ero1α overexpression, mitochondrial Ca2+ uniporter activity measurement, live-cell Ca2+ imaging, MAM fractionation","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — bidirectional genetic manipulation with multiple Ca2+ measurement readouts and MAM localization validation","pmids":["21854214"],"is_preprint":false},{"year":2011,"finding":"ERO1α specifically interacts with PDI via its protruding β-hairpin engaging the hydrophobic pocket of the PDI b'-domain, leading to preferential oxidation of the C-terminal PDI a'-domain. ERO1α associates preferentially with reduced PDI. ERp44 inhibits ERO1α-dependent PDI oxidation when an ERp44 mutant lacking the C-terminal tail is used.","method":"Docking simulations, systematic biochemical analysis, mixed-disulfide trapping, domain-specific oxidation assays, ERp44 interaction analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural docking combined with biochemical domain dissection and mutagenesis","pmids":["21398518"],"is_preprint":false},{"year":2012,"finding":"Hyperactive Ero1α (C104A/C131A mutant) leads to hyperoxidation of ERp57 and induces UPR targets BiP and HERP; these effects are mediated through oxidative perturbation of the ER glutathione redox buffer (reversed by NAC, aggravated by BSO). No broad cytosolic antioxidant response is triggered; oxidative challenge is addressed within the ER lumen.","method":"Ero1α hyperactive mutant overexpression, microarray transcriptomics, NAC/BSO pharmacological manipulation, cell viability assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — hyperactive mutant plus pharmacological rescue with mechanistic interpretation, single lab","pmids":["23027870"],"is_preprint":false},{"year":2013,"finding":"Ero1α is identified as interacting with ERp46, ERp57, and P5 (in addition to PDI) by proteomic analysis and surface plasmon resonance; PDI induces conformational flexibility in Ero1α shuttle cysteine Cys99 facilitating intramolecular electron transfer to the active site. PDI preferentially oxidizes other oxidoreductases via its a' domain (bypassing the a domain which accepts electrons from reduced glutathione).","method":"Proteomic co-immunoprecipitation of Ero1α-associated proteins, surface plasmon resonance, kinetic measurements, redox equilibrium analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — SPR quantitative binding plus proteomics plus kinetic/redox equilibrium measurements in one study","pmids":["24043701"],"is_preprint":false},{"year":2013,"finding":"GPx7 utilizes Ero1α-produced H2O2 to promote oxidative protein folding via PDI; H2O2 oxidizes GPx7 Cys57 to sulfenic acid, resolved by Cys86 to form an intramolecular disulfide; both sulfenic acid and disulfide forms of GPx7 can oxidize PDI. GPx7 preferentially interacts with PDI a domain. This Ero1α/GPx7/PDI triad generates two disulfide bonds per O2 consumed.","method":"In vitro oxidative folding assay, mutagenesis of GPx7 cysteines, in vivo (cell-based) complementation, interaction domain mapping","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution and mutagenesis plus in vivo validation, mechanistic characterization of entire triad","pmids":["23919619"],"is_preprint":false},{"year":2013,"finding":"Ero1α and peroxiredoxin 4 (Prx4) share similar intracellular localization mechanisms in the early secretory compartment: sequential interactions with PDI (preferentially for Ero1α) and ERp44 (equally for both) prevent their secretion in a KDEL/RDEL-dependent manner.","method":"Co-immunoprecipitation, secretion assays, ER retention competition assays with PDI and ERp44","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical co-IP and functional retention assays, single lab","pmids":["23979138"],"is_preprint":false},{"year":2014,"finding":"PDI serves dual roles with Ero1α: either catalytic domain (a or a') rapidly facilitates formation of Ero1α regulatory disulfides (PDI as regulator, independent of substrate-binding domain), while activated Ero1α specifically binds PDI via hydrophobic interactions and preferentially oxidizes domain a' (PDI as substrate). Several PDI family members are potent regulators of Ero1α activity.","method":"In vitro oxidase assay, PDI domain mutants, biochemical interaction assays, redox equilibrium analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with domain-specific mutants revealing asymmetric dual regulation mechanism","pmids":["25258311"],"is_preprint":false},{"year":2014,"finding":"Specific PDI family members (PDI and ERp46) catalyze the formation of regulatory disulfides in Ero1α to inactivate it; molecular oxygen and H2O2 are inefficient at forming the correct regulatory disulfides. Both active sites of PDI contribute to regulatory disulfide formation in Ero1α, and PDI's substrate-binding domain is required for efficient electron transfer.","method":"In vitro regulatory disulfide formation assay under controlled O2, site-directed mutagenesis of PDI active sites, PDI substrate-binding domain mutants","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis establishing a feedback inactivation mechanism","pmids":["24758166"],"is_preprint":false},{"year":2014,"finding":"Bisphenol A (BPA) inhibits Ero1α-catalyzed PDI oxidation by blocking the interaction between the PDI b'-domain and the Ero1α β-hairpin; the phenol groups of BPA compete with the conserved tryptophan in Ero1α's protruding β-hairpin for binding to PDI. BPA slows PDI reoxidation and causes PDI reduction in HeLa cells. BPA does not affect the PDI-Prx4 interaction.","method":"In vitro Ero1α-PDI oxidation assay with BPA, structural analysis (crystallography of PDI-BPA complex), cell-based PDI redox assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzyme assay with structural validation and cell-based redox confirmation","pmids":["25122773"],"is_preprint":false},{"year":2015,"finding":"CHOP promotes hepatocellular injury in acute liver failure through upregulation of ERO1α; CHOP-deficient mice show decreased ERO1α expression and reduced ROS-induced cell death; ERO1α overexpression restores injury in CHOP-deficient mice, demonstrating epistasis: CHOP→ERO1α→ROS.","method":"CHOP knockout mouse model, ERO1α overexpression rescue experiment, in vivo ALF model (GalN/LPS), in vitro siRNA","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with KO and reconstitution in vivo, single lab","pmids":["25387528"],"is_preprint":false},{"year":2015,"finding":"ERO1-α is required for oxidative folding of MHC class I heavy chains; it associates with PDI, calnexin, and immature MHC class I before peptide-loading complex assembly. ERO1-α regulates the redox state and cell-surface expression of MHC class I, altering susceptibility to CD8+ T cell killing.","method":"Co-immunoprecipitation (ERO1α with PDI, calnexin, MHC class I), ERO1α siRNA knockdown, flow cytometry of surface MHC class I, CTL killing assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP establishing complex membership plus functional knockdown with defined immunological readout","pmids":["25870246"],"is_preprint":false},{"year":2015,"finding":"Cysteines 208 and 241 in Ero1α function beyond negative regulation; their mutation lowers the turnover rate under reducing conditions, identifying a positive catalytic role. A reciprocal crosstalk exists between the stability of the Cys208-Cys241 disulfide and the inhibitory disulfides involving Cys104/Cys131; GPx8 recruitment to Ero1α is controlled by the Cys208/Cys241 redox state.","method":"Site-directed mutagenesis, in vitro oxidase activity assays, reductive stimulation experiments, GPx8 co-immunoprecipitation","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzyme mutagenesis with mechanistic interpretation, single lab","pmids":["26609561"],"is_preprint":false},{"year":2016,"finding":"The Cys208-Cys241 disulfide in Ero1α is reduced by PDI and other PDI family members during PDI oxidation; this disulfide pair provides a platform for functional interaction with PDI that enhances Ero1α oxidative activity. Mutation of Cys208/Cys241 does not affect overall Ero1α structure (confirmed by DSC and SAXS), establishing a purely functional regulatory role for this pair.","method":"In vitro PDI oxidation assay, differential scanning calorimetry (DSC), small-angle X-ray scattering (SAXS), site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with structural validation (DSC and SAXS) plus mutagenesis","pmids":["27703014"],"is_preprint":false},{"year":2016,"finding":"ERO1-α promotes production of PD-L1 in breast cancer cells via two mechanisms: facilitating oxidative folding of PD-L1 protein and increasing HIF-1α protein expression, which in turn elevates PD-L1 mRNA; ERO1-α depletion reduces tumor PD-L1 and inhibits Jurkat T cell apoptosis induced by tumor PD-L1.","method":"ERO1-α siRNA/overexpression, PD-L1 flow cytometry, HIF-1α western blotting, Jurkat co-culture apoptosis assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional manipulation with protein folding and signaling readouts, single lab","pmids":["28160557"],"is_preprint":false},{"year":2017,"finding":"ERO1α KO by CRISPR/Cas9 in HCT116 colorectal cancer cells changes integrin-β1 glycosylation, reduces cell-surface integrin-β1 expression specifically under hypoxia, and results in contact-inhibited morphology and diminished cell motility. This establishes a link between ERO1α expression and integrin-β1 activation under hypoxic conditions.","method":"CRISPR/Cas9 knockout, glycosylation analysis, flow cytometry of surface integrin-β1, cell motility and proliferation assays under normoxia/hypoxia","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined glycoprotein and cell biological phenotype, single lab","pmids":["28839225"],"is_preprint":false},{"year":2018,"finding":"TAM-secreted CCL2 induces ERO1-α upregulation in non-neoplastic MCF10A breast epithelial cells; ERO1-α is required for TAM-induced MMP-9 upregulation and invasive phenotype involving transcription factors c-Fos and c-Jun.","method":"Indirect co-culture system, comparative proteomics, ERO1-α siRNA, cytokine array, MMP-9 assay, invasion assay","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics identification plus siRNA functional validation with defined signaling readout","pmids":["30165193"],"is_preprint":false},{"year":2018,"finding":"Fam20C (Golgi casein kinase) phosphorylates Ero1α at Ser145, greatly enhancing its oxidase activity. This phosphorylation occurs in the Golgi and Ero1α is then retrograde-transported to the ER via ERp44. Fam20C depletion results in a more reduced ER; phosphorylation is induced under hypoxia, reductive stress, and lactation.","method":"Co-immunoprecipitation of Fam20C with ER luminal proteins, in vitro kinase assay, Ser145 phospho-mutants, ER redox assay, MS phosphorylation site identification, ERp44 dependence assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus site identification by MS plus functional phospho-mutants plus cell-based ER redox readout","pmids":["29858230"],"is_preprint":false},{"year":2016,"finding":"FBXO6, a substrate recognition component of the SCF E3 ubiquitin ligase, mediates polyubiquitination and proteasomal degradation of the N-glycoprotein Ero1L; FBXO6 overexpression increases Ero1L polyubiquitination and decreases its stability, while FBXO6 inhibition prolongs Ero1L half-life.","method":"Co-immunoprecipitation, in vivo ubiquitination assay, Ero1L stability/half-life assay, FBXO6 overexpression/knockdown","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ubiquitination assay plus stability assay, single lab","pmids":["27855403"],"is_preprint":false},{"year":2022,"finding":"Ero1α-mediated SR oxidation causes dissociation of intraluminal ERp44 from the RyR2 Ca2+ channel via a redox-sensitive interaction involving RyR2 Cys4806; Ero1α inhibition (EN460) or genetic knockdown normalizes SR redox, restores ERp44-RyR2 association, increases Ca2+ transient amplitude, and reduces proarrhythmic spontaneous Ca2+ waves in hypertrophic cardiomyocytes.","method":"Pharmacological inhibition (EN460), Ero1α overexpression, site-directed mutagenesis of RyR2-Cys4806, molecular dynamics simulation, Ca2+ imaging, ERroGFP SR redox biosensor, animal model (TAB)","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis identifying specific cysteine, molecular dynamics, live SR redox sensor, and animal disease model, multiple orthogonal methods","pmids":["35086342"],"is_preprint":false},{"year":2022,"finding":"Ero1α S-nitrosation by inducible nitric oxide synthase (iNOS) decreases its oxidase activity, causing ER reductive stress during replicative senescence. Inhibition of iNOS decreases Ero1α S-nitrosation and senescence; expression of constitutively active Ero1α restores ER oxidizing state and rescues senescent phenotypes.","method":"ER-specific fluorescent redox probes (glutathione and H2O2 sensors), ER-specific catalase model, Ero1α S-nitrosation detection, iNOS inhibition, constitutively active Ero1α overexpression","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — PTM identification (S-nitrosation) with functional rescue by constitutively active Ero1α, single lab","pmids":["35033630"],"is_preprint":false},{"year":2022,"finding":"On the platelet surface, Ero1α constitutively oxidizes PDI and further regulates platelet aggregation in a glutathione-dependent manner; the Ero1α/PDI system oxidizes GSH and establishes the reduction potential optimal for platelet aggregation. Oxidized (not reduced) PDI promotes platelet aggregation.","method":"Platelet redox assay, Ero1α inhibitor (EN460), PDI redox state measurement, glutathione manipulation, platelet aggregation assay","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical demonstration of extracellular Ero1α/PDI/GSH electron transport with functional aggregation readout, single lab","pmids":["35077997"],"is_preprint":false},{"year":2022,"finding":"ERO1 deficiency retards disulfide bond formation in VEGF121 and increases utilization of its single N-glycosylation sequon; ERO1-KO cells show increased interaction of VEGF121 with N-glycosylation pathway proteins, particularly MAGT1 (a thioredoxin-containing component of the post-translational OST complex). ERO1 is thus a physiologic regulator of protein N-glycosylation.","method":"ERO1-KO cells, mass spectrometry (unbiased interaction proteomics), N-glycosylation assay, VEGF121 secretion assay","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO cells with unbiased MS interactomics and defined glycoprotein readout, single lab","pmids":["36063727"],"is_preprint":false},{"year":2022,"finding":"SUMOylation of ERp44 at Lys76 by Ubc9 enhances its covalent binding to Ero1α and ER retention; loss of ERp44 SUMOylation promotes ERp44 degradation and Ero1α secretion, thereby reducing ER stress.","method":"Adipocyte-specific Ubc9 KO mice, LC-MS identification of SUMOylated ERp44, K76 mutation, ERp44-Ero1α co-immunoprecipitation, Ero1α secretion assay","journal":"Metabolism: clinical and experimental","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-identified SUMOylation site with functional co-IP and in vivo KO model, single lab","pmids":["36427672"],"is_preprint":false},{"year":2023,"finding":"ERO1A ablation in tumor cells impairs the balance between IRE1α and PERK signaling, induces lethal unfolded protein responses, and promotes immunogenic cell death, enhancing anti-tumor T cell immunity and the efficacy of anti-PD-1 therapy.","method":"ERO1A genetic ablation in tumor cells, single-cell RNA-sequencing of tumor microenvironment, UPR pathway analysis, immunogenic cell death assay, anti-PD-1 therapeutic models","journal":"Cell reports. Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic ablation with scRNA-seq and mechanistic UPR pathway analysis, single lab","pmids":["37769655"],"is_preprint":false},{"year":2023,"finding":"Platelet ERO1α localizes exclusively in the dense tubular system and promotes Ca2+ mobilization, platelet activation, and aggregation by directly interacting with STIM1 and SERCA2, modifying an allosteric Cys49-Cys56 disulfide in STIM1 and a Cys875-Cys887 disulfide in SERCA2. Mutant STIM1-Cys49/56Ser and SERCA2-Cys875/887Ser show impaired ERO1α interactions.","method":"Megakaryocyte-specific and global Ero1α KO mice, intravital microscopy, mass spectrometry, electron microscopy, site-directed mutagenesis of STIM1 and SERCA2 cysteines, Ca2+ mobilization assay, biochemical co-IP","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic KO with MS identification plus site-directed mutagenesis of substrate cysteines plus multiple functional readouts in vivo and in vitro","pmids":["37132383"],"is_preprint":false},{"year":2024,"finding":"ERO1A is a functional downstream target of mTORC1; elevated ERO1α promotes ferroptosis resistance via upregulation of SLC7A11 through activation of the IL-6/STAT3 signaling pathway; ERO1α stimulates SLC7A11 transcription via IL-6/STAT3-mediated promoter activation.","method":"mTORC1-activated cell models, RNA-seq, cytokine array, ELISA, luciferase reporter assay, chromatin immunoprecipitation, in vivo xenograft and patient-derived xenograft models","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase reporter establishing transcriptional mechanism plus in vivo validation, single lab","pmids":["38610018"],"is_preprint":false},{"year":2024,"finding":"ERO1A interacts with SEPN1 (selenoprotein N) at the MAM; ERO1A depletion in SEPN1 KO cells restores ER redox, re-equilibrates MAM contacts, and rescues mitochondrial bioenergetics and diaphragmatic weakness. ERO1A KO in a SEPN1-loss mouse background blunts ER stress and improves MAM Ca2+ levels and bioenergetics.","method":"Co-immunoprecipitation (ERO1A-SEPN1), ERO1A KO in SEPN1-KO mouse model, ER redox assay, MAM fractionation, Ca2+ measurements, respiratory chain assay, diaphragm contractility assay","journal":"Cell reports. Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct interaction demonstrated by co-IP, functional double-KO rescue in vivo across multiple readouts","pmids":["38402623"],"is_preprint":false},{"year":2024,"finding":"Specific deletion of ERO1-1α (but not ERO-1β) significantly attenuates palmitate-induced oxidative ER stress, ER Ca2+ dysregulation, mitochondrial H2O2 accumulation, and β-cell death; overexpression of redox-active ERO-1α has the opposite proapoptotic effect.","method":"ERO-1α-specific knockout (CRISPR), ERO-1α overexpression, ER-targeted H2O2 and redox sensors, mitochondrial membrane potential assay, Ca2+ imaging, insulin secretion assay","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific KO and OE with multiple compartment-specific readouts, single lab","pmids":["38692092"],"is_preprint":false},{"year":2025,"finding":"SIRT5 desuccinylates ERO1A at Lys396; under simulated microgravity, SIRT5 is downregulated and ERO1A Lys396 succinylation increases, promoting vascular endothelial cell apoptosis. SIRT5 overexpression protects HUVECs from apoptosis and knockdown of SIRT5 induces apoptosis through ERO1A Lys396 succinylation.","method":"LC-MS/MS quantitative succinylome, immunoprecipitation-western blot for Lys396 succinylation, SIRT5 overexpression/knockdown, HUVEC apoptosis assay","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS site identification plus gain/loss-of-function with defined apoptosis readout, single lab","pmids":["40243486"],"is_preprint":false},{"year":2025,"finding":"METTL3-mediated m6A modification of ERO1A mRNA negatively regulates its expression in trophoblasts; METTL3 knockdown elevates ERO1A expression via m6A-dependent mechanism and promotes trophoblast migration and invasion; ERO1A inhibition diminishes the pro-migratory effect of METTL3 depletion.","method":"MeRIP-qPCR (m6A-IP), METTL3 knockdown/overexpression, ERO1A functional rescue, trophoblast migration/invasion assays","journal":"Placenta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MeRIP-qPCR establishing m6A modification of specific transcript plus epistatic rescue experiment, single lab","pmids":["40652673"],"is_preprint":false},{"year":2020,"finding":"ERO1L-mediated ROS generation is essential for its oncogenic activities in pancreatic cancer; an inactive mutant (ERO1-C394A) fails to promote tumor growth, demonstrating catalytic activity requirement. ERO1L regulates the Warburg effect and aerobic glycolysis, with glycolysis inhibition partially abrogating its growth-promoting activity.","method":"ERO1L wild-type vs C394A inactive mutant overexpression, EN460 inhibitor, in vitro proliferation and in vivo xenograft assays, glycolysis inhibitor rescue","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — active-site mutant comparison with functional readout, single lab","pmids":["32724477"],"is_preprint":false}],"current_model":"ERO1A is an ER-localized flavoenzyme (FAD-dependent) that acts as the primary sulfhydryl oxidase for oxidative protein folding: it transfers oxidizing equivalents to PDI via a cyclic disulfide relay involving two conserved cysteine triads (Cys94/99 active site and Cys394/397 outer active site) and a flexible regulatory loop (Cys104/131 and Cys208/241), generating H2O2 as a byproduct; its activity is tightly regulated through intramolecular regulatory disulfide switches and a feedback loop in which reduced PDI activates—and oxidized PDI inactivates—the enzyme. Ero1α is enriched in the MAM subdomain of the ER, where it regulates Ca2+ fluxes toward mitochondria via IP3R (regulated by CHOP-dependent induction under ER stress) and RyR2 (via ERp44 dissociation). Ero1α is retained in the ER by dynamic covalent interactions with ERp44 and non-covalent interactions with PDI, and is regulated post-translationally by Fam20C phosphorylation (Ser145, activating), FBXO6-mediated ubiquitination and degradation, iNOS-mediated S-nitrosation (inactivating), and SIRT5-regulated succinylation at Lys396. On platelets, extracellular Ero1α oxidizes PDI and modifies disulfide bonds in STIM1 (Cys49-Cys56) and SERCA2 (Cys875-Cys887) to promote Ca2+ mobilization and aggregation. In cancer and hypoxia, Ero1α is transcriptionally induced by HIF-1α and CHOP to support secretion of disulfide-rich proteins (VEGFA, PD-L1, MHC class I, adiponectin) and to drive pro-tumorigenic signaling including the IL-6/STAT3/SLC7A11 axis."},"narrative":{"mechanistic_narrative":"ERO1A (Ero1α) is a FAD-dependent, ER-resident type II membrane sulfhydryl oxidase that serves as a primary engine of oxidative protein folding by feeding oxidizing equivalents into protein disulfide isomerase (PDI) [PMID:10671517, PMID:20802462]. It catalyzes disulfide bond formation through a cyclic relay involving two conserved cysteine triads (the Cys85-Cys94-Cys99 active site and the Cys391-Cys394-Cys397 outer site), with Cys94 forming the mixed disulfide that transfers oxidizing power to PDI; mutation of Cys394 or Cys397 abolishes activity [PMID:10671517, PMID:15136577]. Specific targeting of PDI is achieved through a protruding β-hairpin that docks into the hydrophobic pocket of the PDI b'-domain, directing preferential oxidation of the PDI a' active site [PMID:20834232, PMID:21398518]. Ero1α activity is tightly self-limiting: regulatory disulfides in a flexible loop (involving Cys104/Cys131 and Cys208/Cys241) toggle the enzyme between active and inactive states, and reduced PDI activates while oxidized PDI inactivates the oxidase, creating a feedback loop that matches output to substrate demand [PMID:18833192, PMID:18971943, PMID:20834232, PMID:24758166, PMID:27703014]. Because the catalytic cycle consumes O2 and generates H2O2, Ero1α is a major source of luminal ER H2O2, which is productively re-used by peroxidases such as GPx7 to drive further PDI oxidation [PMID:20095866, PMID:23919619]. The enzyme is dynamically retained in the early secretory pathway through covalent binding to ERp44 and non-covalent association with PDI, which also chaperones it against aggregation [PMID:16677073, PMID:23979138]. Layered post-translational controls tune its activity and abundance: Fam20C phosphorylation at Ser145 activates the oxidase, FBXO6-directed ubiquitination drives its proteasomal degradation, ERp44 SUMOylation governs its ER retention versus secretion, iNOS-mediated S-nitrosation inactivates it, and SIRT5-reversed Lys396 succinylation modulates its pro-apoptotic activity [PMID:29858230, PMID:27855403, PMID:36427672, PMID:35033630, PMID:40243486]. Functionally, Ero1α supports secretion and folding of disulfide-rich clients including adiponectin, VEGF, MHC class I, PD-L1 and Notch [PMID:17452443, PMID:15592500, PMID:25870246, PMID:28160557, PMID:18809725], and it is enriched at the mitochondria-associated ER membrane where it shapes Ca2+ fluxes toward mitochondria and is wired into ER-stress apoptosis via CHOP-dependent induction and IP3R1 stimulation [PMID:20186508, PMID:21854214, PMID:19752026]. On the platelet surface and dense tubular system, extracellular Ero1α oxidizes PDI and modifies allosteric disulfides in STIM1 (Cys49-Cys56) and SERCA2 (Cys875-Cys887) to promote Ca2+ mobilization and aggregation [PMID:20562109, PMID:35077997, PMID:37132383]. In cancer and hypoxia, HIF-1α- and CHOP-driven Ero1α supports tumor secretion and pro-tumorigenic signaling, including an mTORC1→Ero1α→IL-6/STAT3/SLC7A11 axis conferring ferroptosis resistance, in a manner dependent on its catalytic activity [PMID:15592500, PMID:38610018, PMID:32724477].","teleology":[{"year":2000,"claim":"Established that the human ERO1 ortholog is a functional ER oxidoreductase, answering whether the yeast oxidative-folding machinery is conserved in mammals.","evidence":"Yeast ero1-1 complementation, microsome fractionation, Endo-H glycan analysis and cysteine mutagenesis","pmids":["10671517"],"confidence":"High","gaps":["Did not define the full disulfide relay to PDI","Cofactor and partner enzymes not yet mapped"]},{"year":2004,"claim":"Defined the dual cysteine-triad electron-transfer architecture and identified PDI and ERp44 as mixed-disulfide partners, establishing how oxidizing equivalents move through the enzyme.","evidence":"Yeast complementation, mutagenesis and mixed-disulfide trapping with PDI/ERp44","pmids":["15136577"],"confidence":"High","gaps":["Atomic-level interface with PDI not resolved","Regulatory disulfide switch not yet defined"]},{"year":2005,"claim":"Connected Ero1α to physiological hypoxic adaptation by showing HIF-1-dependent induction supports secretion of disulfide-rich VEGF, framing it as the adaptive oxidoreductase under low oxygen.","evidence":"HIF-1-deficient cell epistasis, siRNA knockdown and VEGF secretion assay under hypoxia","pmids":["15592500"],"confidence":"High","gaps":["Did not address other hypoxic clients","Mechanism of catalysis under low O2 not addressed"]},{"year":2006,"claim":"Resolved how a soluble-pathway oxidase is kept in the ER, showing competing covalent ERp44 and non-covalent PDI interactions retain and chaperone Ero1α.","evidence":"Secretion/retention assays and co-IP in HeLa with dominant-negative PDI mutants","pmids":["16677073"],"confidence":"High","gaps":["Quantitative affinities not determined","How retention is dynamically modulated not addressed"]},{"year":2008,"claim":"Uncovered the intramolecular disulfide switch and substrate-feedback logic that prevents hyperoxidation, answering how the enzyme avoids runaway activity.","evidence":"MS identification of a Cys94-Cys131 regulatory disulfide, cell-based oxidation assays, mutants, isoform comparison, plus in vitro redox potential measurements; and in vivo demonstration that CHOP induces Ero1α to stimulate IP3R1-mediated Ca2+ apoptosis and that Ero1α oxidizes Notch LNR disulfides in Drosophila","pmids":["18833192","18971943","19752026","18809725"],"confidence":"High","gaps":["Structural basis of loop rearrangement not yet visualized","Full roster of regulatory cysteines incomplete"]},{"year":2010,"claim":"Provided atomic and quantitative mechanism: crystal structures in two redox states plus kinetic assays showed PDI reduction potential and loop disulfides set the rate of catalysis, and localization/imaging tied Ero1α to the MAM, luminal H2O2 production, and ER-mitochondria Ca2+ fluxes.","evidence":"X-ray crystallography, dual active-site PDI redox kinetics, ER-targeted H2O2 sensor, MAM fractionation and Ca2+ imaging, plus platelet-surface co-IP and aggregation assays","pmids":["20834232","20657012","20095866","20186508","21854214","20802462","20130085","20562109"],"confidence":"High","gaps":["In vivo significance of MAM enrichment not fully tested","Identity of all MAM Ca2+ effectors incomplete"]},{"year":2013,"claim":"Expanded the oxidoreductase network and refined how PDI both regulates and is a substrate, showing Ero1α partners with multiple PDI-family members and forms a peroxidase relay with GPx7 that reuses H2O2.","evidence":"Proteomic co-IP, SPR, in vitro folding assays with GPx7 cysteine mutants and domain mapping","pmids":["24043701","23919619"],"confidence":"High","gaps":["Relative flux through PDI vs GPx7/GSH routes in vivo unquantified","Selectivity among PDI-family partners not fully resolved"]},{"year":2014,"claim":"Dissected the asymmetric dual role of PDI as both regulator and substrate and identified small-molecule (BPA) interference, clarifying the feedback inactivation logic.","evidence":"In vitro oxidase assays with PDI domain mutants, regulatory disulfide formation under controlled O2, and structural/cell-based analysis of BPA inhibition","pmids":["25258311","24758166","25122773"],"confidence":"High","gaps":["Cellular concentrations driving regulator vs substrate modes unknown","Physiological relevance of BPA exposure not established"]},{"year":2015,"claim":"Refined the regulatory cysteine map by assigning a positive catalytic and PDI-interaction role to Cys208/Cys241, and extended client/disease scope to MHC class I folding and CHOP-driven liver injury.","evidence":"Mutagenesis with in vitro oxidase assays and GPx8 co-IP; co-IP/knockdown for MHC class I; CHOP-KO mouse with Ero1α rescue in acute liver failure","pmids":["26609561","25870246","25387528"],"confidence":"Medium","gaps":["Structural impact of Cys208/Cys241 minimal but functional role mechanism partial","MHC class I and liver findings from single labs"]},{"year":2018,"claim":"Identified post-translational activation by Fam20C phosphorylation and degradation by FBXO6, establishing kinase- and ubiquitin-based control over Ero1α levels and activity.","evidence":"In vitro kinase assay with MS site mapping and phospho-mutants; in vivo ubiquitination and half-life assays; plus TAM/CCL2-induced upregulation driving invasion","pmids":["29858230","27855403","30165193"],"confidence":"Medium","gaps":["Crosstalk between phosphorylation, degradation and redox switches unresolved","Upstream signals coordinating these PTMs incomplete"]},{"year":2022,"claim":"Established Ero1α as a redox node controlling Ca2+ handling in distinct tissues and as a target of multiple PTMs, by identifying its substrate cysteines on RyR2 and its inactivation by S-nitrosation and its ERp44-SUMO-controlled retention.","evidence":"RyR2-Cys4806 mutagenesis with SR redox biosensor and animal model; iNOS S-nitrosation with constitutively active Ero1α rescue; ERp44 SUMOylation co-IP with Ubc9-KO mice; platelet GSH redox assays; ERO1-KO interactomics linking it to N-glycosylation via MAGT1","pmids":["35086342","35033630","36427672","35077997","36063727"],"confidence":"High","gaps":["Integration of these PTMs into a single regulatory hierarchy unclear","Tissue specificity of substrate disulfide modification not generalized"]},{"year":2023,"claim":"Connected Ero1α to UPR balance and tumor immunity, showing its ablation skews IRE1α/PERK signaling toward immunogenic cell death and enhances anti-PD-1 efficacy.","evidence":"Genetic ablation in tumor cells with scRNA-seq, UPR analysis and anti-PD-1 therapeutic models","pmids":["37769655"],"confidence":"Medium","gaps":["Direct molecular link between Ero1α loss and UPR branch imbalance not mapped","Single-lab tumor models"]},{"year":2024,"claim":"Placed Ero1α downstream of mTORC1 in cancer metabolism and within MAM/muscle physiology, defining an IL-6/STAT3/SLC7A11 ferroptosis-resistance axis and a SEPN1 interaction governing ER redox and bioenergetics.","evidence":"mTORC1 cell models with ChIP and luciferase reporter plus xenografts; ERO1A-SEPN1 co-IP with double-KO mouse rescue; isoform-specific KO in palmitate-stressed β-cells","pmids":["38610018","38402623","38692092"],"confidence":"Medium","gaps":["Mechanism by which mTORC1 elevates Ero1α not fully defined","Single-lab disease models"]},{"year":2025,"claim":"Extended PTM regulation to SIRT5-reversed Lys396 succinylation and m6A-based mRNA control, linking Ero1α to endothelial apoptosis and trophoblast invasion.","evidence":"Quantitative succinylome/MS with SIRT5 gain/loss in HUVECs; MeRIP-qPCR with METTL3 manipulation and ERO1A rescue in trophoblasts","pmids":["40243486","40652673"],"confidence":"Medium","gaps":["Effect of Lys396 succinylation on catalytic mechanism not biochemically resolved","Single-lab, context-specific findings"]},{"year":null,"claim":"How the many layers of regulation (intramolecular disulfide switches, phosphorylation, ubiquitination, S-nitrosation, succinylation, SUMO-controlled retention, m6A) are integrated to set Ero1α activity in specific cell types and disease states remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking PTM hierarchy to redox switching","In vivo flux balance between Ero1α, GPx7/8, Prx4 and glutathione routes unquantified","Therapeutic consequences of selective Ero1α inhibition across tissues untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,6,14,46]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[15,17,40]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,15]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,2,11]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13,36,40]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,15,20]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[7,8,39]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[13,36,40]}],"complexes":[],"partners":["P4HB","ERP44","ERP46","ERP57","GPX7","GPX8","STIM1","ATP2A2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96HE7","full_name":"ERO1-like protein alpha","aliases":["Endoplasmic oxidoreductin-1-like protein","Endoplasmic reticulum oxidoreductase alpha","Oxidoreductin-1-L-alpha"],"length_aa":468,"mass_kda":54.4,"function":"Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to sustain additional rounds of disulfide formation. Following P4HB reoxidation, passes its electrons to molecular oxygen via FAD, leading to the production of reactive oxygen species (ROS) in the cell. Required for the proper folding of immunoglobulins (PubMed:29858230). Plays an important role in ER stress-induced, CHOP-dependent apoptosis by activating the inositol 1,4,5-trisphosphate receptor IP3R1. Involved in the release of the unfolded cholera toxin from reduced P4HB/PDI in case of infection by V.cholerae, thereby playing a role in retrotranslocation of the toxin","subcellular_location":"Endoplasmic reticulum membrane; Golgi apparatus lumen; Secreted; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/Q96HE7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ERO1A","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ERO1A","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"esophagus","ntpm":169.0}],"url":"https://www.proteinatlas.org/search/ERO1A"},"hgnc":{"alias_symbol":["ERO1-alpha","Ero1alpha"],"prev_symbol":["ERO1L"]},"alphafold":{"accession":"Q96HE7","domains":[{"cath_id":"-","chopping":"38-115_164-466","consensus_level":"high","plddt":81.4611,"start":38,"end":466}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96HE7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96HE7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96HE7-F1-predicted_aligned_error_v6.png","plddt_mean":75.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ERO1A","jax_strain_url":"https://www.jax.org/strain/search?query=ERO1A"},"sequence":{"accession":"Q96HE7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96HE7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96HE7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96HE7"}},"corpus_meta":[{"pmid":"19752026","id":"PMC_19752026","title":"Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19752026","citation_count":511,"is_preprint":false},{"pmid":"10671517","id":"PMC_10671517","title":"ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10671517","citation_count":261,"is_preprint":false},{"pmid":"17452443","id":"PMC_17452443","title":"Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17452443","citation_count":236,"is_preprint":false},{"pmid":"21854214","id":"PMC_21854214","title":"Ero1α regulates Ca(2+) fluxes at the endoplasmic reticulum-mitochondria interface (MAM).","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21854214","citation_count":185,"is_preprint":false},{"pmid":"20186508","id":"PMC_20186508","title":"Ero1alpha requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM).","date":"2010","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/20186508","citation_count":163,"is_preprint":false},{"pmid":"18833192","id":"PMC_18833192","title":"A novel disulphide switch mechanism in Ero1alpha balances ER oxidation in human cells.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18833192","citation_count":154,"is_preprint":false},{"pmid":"15592500","id":"PMC_15592500","title":"Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15592500","citation_count":141,"is_preprint":false},{"pmid":"18971943","id":"PMC_18971943","title":"Low reduction potential of Ero1alpha regulatory disulphides ensures tight control of substrate oxidation.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18971943","citation_count":125,"is_preprint":false},{"pmid":"24043701","id":"PMC_24043701","title":"Ero1-α and PDIs constitute a hierarchical electron transfer network of endoplasmic reticulum oxidoreductases.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24043701","citation_count":122,"is_preprint":false},{"pmid":"20095866","id":"PMC_20095866","title":"Redox state of the endoplasmic reticulum is controlled by Ero1L-alpha and intraluminal calcium.","date":"2010","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20095866","citation_count":119,"is_preprint":false},{"pmid":"20802462","id":"PMC_20802462","title":"Disulphide production by Ero1α-PDI relay is rapid and effectively regulated.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20802462","citation_count":119,"is_preprint":false},{"pmid":"20834232","id":"PMC_20834232","title":"Crystal structures of human Ero1α reveal the mechanisms of regulated and targeted oxidation of PDI.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20834232","citation_count":116,"is_preprint":false},{"pmid":"23919619","id":"PMC_23919619","title":"Glutathione peroxidase 7 utilizes hydrogen peroxide generated by Ero1α to promote oxidative protein folding.","date":"2013","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23919619","citation_count":100,"is_preprint":false},{"pmid":"16677073","id":"PMC_16677073","title":"Dynamic retention of Ero1alpha and Ero1beta in the endoplasmic reticulum by interactions with PDI and ERp44.","date":"2006","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/16677073","citation_count":90,"is_preprint":false},{"pmid":"32724477","id":"PMC_32724477","title":"Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32724477","citation_count":89,"is_preprint":false},{"pmid":"30165193","id":"PMC_30165193","title":"Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-α and MMP-9.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30165193","citation_count":74,"is_preprint":false},{"pmid":"21398518","id":"PMC_21398518","title":"Molecular bases of cyclic and specific disulfide interchange between human ERO1alpha protein and protein-disulfide isomerase (PDI).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21398518","citation_count":71,"is_preprint":false},{"pmid":"25387528","id":"PMC_25387528","title":"C/EBP homologous protein (CHOP) contributes to hepatocyte death via the promotion of ERO1α signalling in acute liver failure.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25387528","citation_count":68,"is_preprint":false},{"pmid":"20657012","id":"PMC_20657012","title":"The reduction potential of the active site disulfides of human protein disulfide isomerase limits oxidation of the enzyme by Ero1α.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20657012","citation_count":68,"is_preprint":false},{"pmid":"18809725","id":"PMC_18809725","title":"Ero1L, a thiol oxidase, is required for Notch signaling through cysteine bridge formation of the Lin12-Notch repeats in Drosophila melanogaster.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18809725","citation_count":61,"is_preprint":false},{"pmid":"28160557","id":"PMC_28160557","title":"Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28160557","citation_count":58,"is_preprint":false},{"pmid":"23979138","id":"PMC_23979138","title":"Dynamic regulation of Ero1α and peroxiredoxin 4 localization in the secretory pathway.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23979138","citation_count":57,"is_preprint":false},{"pmid":"25258311","id":"PMC_25258311","title":"Different interaction modes for protein-disulfide isomerase (PDI) as an efficient regulator and a specific substrate of endoplasmic reticulum oxidoreductin-1α (Ero1α).","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25258311","citation_count":57,"is_preprint":false},{"pmid":"23027870","id":"PMC_23027870","title":"Hyperactivity of the Ero1α oxidase elicits endoplasmic reticulum stress but no broad antioxidant response.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23027870","citation_count":56,"is_preprint":false},{"pmid":"29858230","id":"PMC_29858230","title":"Secretory kinase Fam20C tunes endoplasmic reticulum redox state via phosphorylation of Ero1α.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29858230","citation_count":52,"is_preprint":false},{"pmid":"27100727","id":"PMC_27100727","title":"Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.","date":"2016","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27100727","citation_count":48,"is_preprint":false},{"pmid":"25595776","id":"PMC_25595776","title":"Cancer-associated oxidoreductase ERO1-α drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25595776","citation_count":48,"is_preprint":false},{"pmid":"15136577","id":"PMC_15136577","title":"Two conserved cysteine triads in human Ero1alpha cooperate for efficient disulfide bond formation in the endoplasmic reticulum.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15136577","citation_count":48,"is_preprint":false},{"pmid":"37769655","id":"PMC_37769655","title":"Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.","date":"2023","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37769655","citation_count":45,"is_preprint":false},{"pmid":"28839225","id":"PMC_28839225","title":"Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28839225","citation_count":45,"is_preprint":false},{"pmid":"24357799","id":"PMC_24357799","title":"ERO1α-dependent endoplasmic reticulum-mitochondrial calcium flux contributes to ER stress and mitochondrial permeabilization by procaspase-activating compound-1 (PAC-1).","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24357799","citation_count":44,"is_preprint":false},{"pmid":"25122773","id":"PMC_25122773","title":"Inhibition of the functional interplay between endoplasmic reticulum (ER) oxidoreduclin-1α (Ero1α) and protein-disulfide isomerase (PDI) by the endocrine disruptor bisphenol A.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25122773","citation_count":44,"is_preprint":false},{"pmid":"33751828","id":"PMC_33751828","title":"The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.","date":"2021","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33751828","citation_count":42,"is_preprint":false},{"pmid":"38610018","id":"PMC_38610018","title":"Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.","date":"2024","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/38610018","citation_count":40,"is_preprint":false},{"pmid":"25870246","id":"PMC_25870246","title":"Cancer-Associated Oxidase ERO1-α Regulates the Expression of MHC Class I Molecule via Oxidative Folding.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25870246","citation_count":40,"is_preprint":false},{"pmid":"20562109","id":"PMC_20562109","title":"Ero1alpha is expressed on blood platelets in association with protein-disulfide isomerase and contributes to redox-controlled remodeling of alphaIIbbeta3.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20562109","citation_count":40,"is_preprint":false},{"pmid":"24022479","id":"PMC_24022479","title":"Endoplasmic reticulum oxidoreductin-1α (Ero1α) improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24022479","citation_count":38,"is_preprint":false},{"pmid":"33056994","id":"PMC_33056994","title":"ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33056994","citation_count":36,"is_preprint":false},{"pmid":"20130085","id":"PMC_20130085","title":"The Ero1alpha-PDI redox cycle regulates retro-translocation of cholera toxin.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20130085","citation_count":34,"is_preprint":false},{"pmid":"35086342","id":"PMC_35086342","title":"Ero1α-Dependent ERp44 Dissociation From RyR2 Contributes to Cardiac Arrhythmia.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/35086342","citation_count":32,"is_preprint":false},{"pmid":"34354701","id":"PMC_34354701","title":"ERO1L Is a Novel and Potential Biomarker in Lung Adenocarcinoma and Shapes the Immune-Suppressive Tumor Microenvironment.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34354701","citation_count":32,"is_preprint":false},{"pmid":"37598403","id":"PMC_37598403","title":"SIRT6 deficiency in endothelial cells exacerbates oxidative stress by enhancing HIF1α accumulation and H3K9 acetylation at the Ero1α promoter.","date":"2023","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37598403","citation_count":30,"is_preprint":false},{"pmid":"35033630","id":"PMC_35033630","title":"ER reductive stress caused by Ero1α S-nitrosation accelerates senescence.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35033630","citation_count":28,"is_preprint":false},{"pmid":"33045621","id":"PMC_33045621","title":"Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/33045621","citation_count":28,"is_preprint":false},{"pmid":"27855403","id":"PMC_27855403","title":"FBXO6-Mediated Ubiquitination and Degradation of Ero1L Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27855403","citation_count":27,"is_preprint":false},{"pmid":"38402623","id":"PMC_38402623","title":"SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.","date":"2024","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38402623","citation_count":26,"is_preprint":false},{"pmid":"37080351","id":"PMC_37080351","title":"Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma.","date":"2023","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37080351","citation_count":26,"is_preprint":false},{"pmid":"27667124","id":"PMC_27667124","title":"Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.","date":"2016","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27667124","citation_count":24,"is_preprint":false},{"pmid":"30076651","id":"PMC_30076651","title":"ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30076651","citation_count":23,"is_preprint":false},{"pmid":"34478920","id":"PMC_34478920","title":"The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis.","date":"2021","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/34478920","citation_count":23,"is_preprint":false},{"pmid":"36063727","id":"PMC_36063727","title":"ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36063727","citation_count":23,"is_preprint":false},{"pmid":"25989620","id":"PMC_25989620","title":"The Hypothermic Influence on CHOP and Ero1-α in an Endoplasmic Reticulum Stress Model of Cerebral Ischemia.","date":"2015","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25989620","citation_count":23,"is_preprint":false},{"pmid":"36427672","id":"PMC_36427672","title":"SUMOylation of ERp44 enhances Ero1α ER retention contributing to the pathogenesis of obesity and insulin resistance.","date":"2022","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/36427672","citation_count":22,"is_preprint":false},{"pmid":"38454454","id":"PMC_38454454","title":"Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.","date":"2024","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/38454454","citation_count":20,"is_preprint":false},{"pmid":"35077997","id":"PMC_35077997","title":"The extracellular Ero1α/PDI electron transport system regulates platelet function by increasing glutathione reduction potential.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35077997","citation_count":20,"is_preprint":false},{"pmid":"31942199","id":"PMC_31942199","title":"MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L.","date":"2020","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31942199","citation_count":20,"is_preprint":false},{"pmid":"24758166","id":"PMC_24758166","title":"Inactivation of mammalian Ero1α is catalysed by specific protein disulfide-isomerases.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24758166","citation_count":20,"is_preprint":false},{"pmid":"34584570","id":"PMC_34584570","title":"circ-ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR-582-5p/ERO1A signaling axis.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34584570","citation_count":20,"is_preprint":false},{"pmid":"34287039","id":"PMC_34287039","title":"Porcine Circovirus 2 Manipulates the PERK-ERO1α Axis of the Endoplasmic Reticulum To Favor Its Replication by Derepressing Viral DNA from HMGB1 Sequestration within Nuclei.","date":"2021","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/34287039","citation_count":20,"is_preprint":false},{"pmid":"37132383","id":"PMC_37132383","title":"A Critical Role for ERO1α in Arterial Thrombosis and Ischemic Stroke.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37132383","citation_count":19,"is_preprint":false},{"pmid":"31142270","id":"PMC_31142270","title":"ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31142270","citation_count":18,"is_preprint":false},{"pmid":"32376276","id":"PMC_32376276","title":"ERO1α inhibits cell apoptosis and regulates steroidogenesis in mouse granulosa cells.","date":"2020","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32376276","citation_count":16,"is_preprint":false},{"pmid":"38692092","id":"PMC_38692092","title":"Non-esterified fatty acid palmitate facilitates oxidative endoplasmic reticulum stress and apoptosis of β-cells by upregulating ERO-1α expression.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38692092","citation_count":16,"is_preprint":false},{"pmid":"33615311","id":"PMC_33615311","title":"The Role of ERO1α in Modulating Cancer Progression and Immune Escape.","date":"2020","source":"Journal of cancer immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33615311","citation_count":15,"is_preprint":false},{"pmid":"31990068","id":"PMC_31990068","title":"ERO1α promotes testosterone secretion in hCG-stimulated mouse Leydig cells via activation of the PI3K/AKT/mTOR signaling pathway.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31990068","citation_count":15,"is_preprint":false},{"pmid":"36346508","id":"PMC_36346508","title":"Silica nanoparticles induce ovarian granulosa cell apoptosis via activation of the PERK-ATF4-CHOP-ERO1α pathway-mediated IP3R1-dependent calcium mobilization.","date":"2022","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36346508","citation_count":15,"is_preprint":false},{"pmid":"27703014","id":"PMC_27703014","title":"Human ER Oxidoreductin-1α (Ero1α) Undergoes Dual Regulation through Complementary Redox Interactions with Protein-Disulfide Isomerase.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27703014","citation_count":15,"is_preprint":false},{"pmid":"32841447","id":"PMC_32841447","title":"ERO1L promotes NSCLC development by modulating cell cycle-related molecules.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/32841447","citation_count":14,"is_preprint":false},{"pmid":"26609561","id":"PMC_26609561","title":"Cysteines 208 and 241 in Ero1α are required for maximal catalytic turnover.","date":"2015","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/26609561","citation_count":14,"is_preprint":false},{"pmid":"33559868","id":"PMC_33559868","title":"ERO1α mediates endoplasmic reticulum stress-induced apoptosis via microRNA-101/EZH2 axis in colon cancer RKO and HT-29 cells.","date":"2021","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/33559868","citation_count":14,"is_preprint":false},{"pmid":"35189109","id":"PMC_35189109","title":"Crosstalk between ERO1α and ryanodine receptor in arsenite-dependent mitochondrial ROS formation.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35189109","citation_count":13,"is_preprint":false},{"pmid":"33681386","id":"PMC_33681386","title":"ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer.","date":"2021","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/33681386","citation_count":13,"is_preprint":false},{"pmid":"23373818","id":"PMC_23373818","title":"Expression of the endoplasmic reticulum oxidoreductase Ero1α in gastro-intestinal cancer reveals a link between homocysteine and oxidative protein folding.","date":"2013","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23373818","citation_count":13,"is_preprint":false},{"pmid":"39962052","id":"PMC_39962052","title":"Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39962052","citation_count":12,"is_preprint":false},{"pmid":"35785492","id":"PMC_35785492","title":"ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β-catenin signaling pathway.","date":"2022","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/35785492","citation_count":11,"is_preprint":false},{"pmid":"36037618","id":"PMC_36037618","title":"Porcine circovirus type 2 induces CHOP-ERO1α-ROS-mediated apoptosis in PK-15 cells.","date":"2022","source":"Veterinary microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36037618","citation_count":10,"is_preprint":false},{"pmid":"35892127","id":"PMC_35892127","title":"Identification of Natural Product Sulfuretin Derivatives as Inhibitors for the Endoplasmic Reticulum Redox Protein ERO1α.","date":"2022","source":"ACS bio & med chem Au","url":"https://pubmed.ncbi.nlm.nih.gov/35892127","citation_count":10,"is_preprint":false},{"pmid":"34512174","id":"PMC_34512174","title":"Endophilin A2-mediated alleviation of endoplasmic reticulum stress-induced cardiac injury involves the suppression of ERO1α/IP3R signaling pathway.","date":"2021","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34512174","citation_count":10,"is_preprint":false},{"pmid":"35347798","id":"PMC_35347798","title":"Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1α expression via cooperation between DNMT1 and G9a.","date":"2022","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/35347798","citation_count":9,"is_preprint":false},{"pmid":"12694393","id":"PMC_12694393","title":"Ero1-L, an ischemia-inducible gene from rat brain with homology to global ischemia-induced gene 11 (Giig11), is localized to neuronal dendrites by a dispersed identifier (ID) element-dependent mechanism.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12694393","citation_count":9,"is_preprint":false},{"pmid":"38187398","id":"PMC_38187398","title":"Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38187398","citation_count":8,"is_preprint":false},{"pmid":"37776473","id":"PMC_37776473","title":"ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.","date":"2023","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/37776473","citation_count":8,"is_preprint":false},{"pmid":"36220374","id":"PMC_36220374","title":"Role of Ero1α in cognitive impairment induced by chronic hypoxia.","date":"2022","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/36220374","citation_count":6,"is_preprint":false},{"pmid":"40243486","id":"PMC_40243486","title":"SIRT5 Alleviates Apoptosis of Vascular Endothelial Cells Under Simulated Microgravity via Desuccinylation of ERO1A.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40243486","citation_count":6,"is_preprint":false},{"pmid":"34712608","id":"PMC_34712608","title":"Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis via Interaction With ERO1A in Human Colorectal Cancer.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34712608","citation_count":6,"is_preprint":false},{"pmid":"39657838","id":"PMC_39657838","title":"Inhibition of ERO1L induces autophagy and apoptosis via endoplasmic reticulum stress in colorectal cancer.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/39657838","citation_count":5,"is_preprint":false},{"pmid":"40616124","id":"PMC_40616124","title":"M2 macrophage-secreted KYNU promotes stemness remodeling and malignant behavior in endometrial cancer via the SOD2-mtROS-ERO1α-UPRER axis.","date":"2025","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/40616124","citation_count":4,"is_preprint":false},{"pmid":"21664357","id":"PMC_21664357","title":"Molecular cloning and characterization of the porcine Ero1L and ERp44 genes: potential roles in controlling energy metabolism.","date":"2011","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21664357","citation_count":4,"is_preprint":false},{"pmid":"41449433","id":"PMC_41449433","title":"ERO1A promotes the proliferation, migration and invasion of bladder cancer through ALOX5 mediated activation of JAK-STAT signaling pathway.","date":"2025","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41449433","citation_count":3,"is_preprint":false},{"pmid":"37659621","id":"PMC_37659621","title":"ERO1α primes the ryanodine receptor to respond to arsenite with concentration dependent Ca2+ release sequentially triggering two different mechanisms of ROS formation.","date":"2023","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/37659621","citation_count":3,"is_preprint":false},{"pmid":"39566653","id":"PMC_39566653","title":"Enhancing S-nitrosoglutathione reductase decreases S-nitrosylation of ERO1α and reduces neuronal death in secondary traumatic brain injury.","date":"2024","source":"Nitric oxide : biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39566653","citation_count":3,"is_preprint":false},{"pmid":"41028408","id":"PMC_41028408","title":"ERO1A-positive tumor epithelial cells in colorectal cancer progression: a multi-omics perspective.","date":"2025","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/41028408","citation_count":2,"is_preprint":false},{"pmid":"37014092","id":"PMC_37014092","title":"Knockdown of ERO1L attenuates tumor growth, migration and invasion in lung adenocarcinoma through Wnt/β‑catenin pathway.","date":"2023","source":"Biotechnology & genetic engineering reviews","url":"https://pubmed.ncbi.nlm.nih.gov/37014092","citation_count":2,"is_preprint":false},{"pmid":"36781116","id":"PMC_36781116","title":"Arsenite enhances ERO1α expression via ryanodine receptor dependent and independent mechanisms.","date":"2023","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36781116","citation_count":2,"is_preprint":false},{"pmid":"35964836","id":"PMC_35964836","title":"Inhibition of activity/expression, or genetic deletion, of ERO1α blunts arsenite geno- and cyto-toxicity.","date":"2022","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/35964836","citation_count":2,"is_preprint":false},{"pmid":"37100971","id":"PMC_37100971","title":"Suppression of Microglial ERO1a Alleviates Inflammation and Enhances the Efficacy of Rehabilitative Training After Ischemic Stroke.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37100971","citation_count":2,"is_preprint":false},{"pmid":"40652673","id":"PMC_40652673","title":"METTL3-dependent m6A modification of ERO1A mRNA regulates trophoblast migration and invasion in early-onset severe preeclampsia.","date":"2025","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/40652673","citation_count":2,"is_preprint":false},{"pmid":"34606425","id":"PMC_34606425","title":"Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studies.","date":"2021","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/34606425","citation_count":2,"is_preprint":false},{"pmid":"40414553","id":"PMC_40414553","title":"Ero1a, the most strongly hypoxia-induced protein in PASMCs, promotes the development of hypoxia- and monocrotaline-induced pulmonary hypertension in rats.","date":"2025","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40414553","citation_count":1,"is_preprint":false},{"pmid":"40203915","id":"PMC_40203915","title":"Functional characterization of key protein biomarkers in spontaneous intracerebral hemorrhage pathogenesis: Structure and function of NUAK1 protein and ERO1L protein macromolecules.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40203915","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53850,"output_tokens":12252,"usd":0.172665,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24081,"output_tokens":5596,"usd":0.130153,"stage2_stop_reason":"end_turn"},"total_usd":0.302818,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Human ERO1-L (ERO1A) is a type II integral membrane protein of the endoplasmic reticulum that favors disulfide bond formation in secretory proteins; it complements the yeast ero1-1 thermosensitive mutant, and its activity requires conserved cysteines Cys-394 and Cys-397 (mutation of either abolishes function).\",\n      \"method\": \"Yeast complementation assay, subcellular fractionation (microsome), Endo-H glycan sensitivity, site-directed mutagenesis of conserved cysteines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (yeast complementation, biochemical fractionation, mutagenesis) in a single study; foundational characterization paper\",\n      \"pmids\": [\"10671517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Two conserved cysteine triads in human Ero1α (Cys85-Cys94-Cys99 and Cys391-Cys394-Cys397) cooperate in electron transfer; Cys94 likely forms the mixed disulfide with PDI; dominant-negative phenotypes arise from mutations in Cys394, Cys397, or Cys99; Ero1α forms mixed disulfides with both PDI and ERp44.\",\n      \"method\": \"Yeast complementation, site-directed mutagenesis, mixed-disulfide trapping with PDI and ERp44, redox-dependent conformational analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution-level mutagenesis combined with multiple functional readouts (yeast complementation, mammalian oxidative folding, mixed-disulfide trapping)\",\n      \"pmids\": [\"15136577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ero1α (and Ero1β) are dynamically retained in the ER via covalent interactions with ERp44 and non-covalent interactions with PDI; PDI and ERp44 compete for Ero1 binding; PDI also prevents Ero1 aggregation/dimerization, chaperoning its own oxidase; retention is KDEL/RDEL-dependent.\",\n      \"method\": \"Co-expression/secretion assay in HeLa cells, co-immunoprecipitation, dominant-negative PDI mutants lacking active-site cysteines\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction mapping with multiple mutants and two distinct ER-retention proteins, single lab\",\n      \"pmids\": [\"16677073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Ero1-Lα is required for secretion of high-molecular-weight adiponectin complexes from adipocytes; siRNA knockdown of Ero1-Lα reduces adiponectin secretion, and ectopic Ero1-Lα expression in Ero1-Lα-deficient fibroblasts stimulates adiponectin secretion after adipogenic conversion.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression in Ero1-Lα-deficient cells, adiponectin secretion ELISA, adipocyte differentiation model (3T3-L1)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function experiments with defined secretory readout, single lab\",\n      \"pmids\": [\"17452443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A disulfide switch regulates Ero1α activity: formation of a disulfide between active-site Cys94 (normally paired with Cys99) and regulatory Cys131 silences the enzyme; PDI (reduced) competes with Cys131 for Cys94, creating a feedback loop linking Ero1α activation to availability of its substrate reduced PDI. The isoform Ero1β lacks an equivalent switch.\",\n      \"method\": \"Mass spectrometry identification of regulatory disulfide, cell-based ER oxidation assay, Ero1α-C131A overexpression, comparison with Ero1β\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — MS-identified regulatory disulfide plus functional cell-based validation and isoform comparison in one rigorous study\",\n      \"pmids\": [\"18833192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In Drosophila, Ero1L is specifically required for disulfide bond formation in the three Lin12-Notch repeats (LNRs) of the Notch extracellular domain; loss of Ero1L causes Notch accumulation in the ER, ER stress, and specific defects in lateral inhibition and inductive signaling.\",\n      \"method\": \"Mosaic genetic screen, biochemical disulfide bond assay of LNR domains, immunofluorescence of Notch localization, UPR reporter assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic screen plus biochemical substrate identification plus in vivo functional phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"18809725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Recombinant human Ero1α has oxidase activity toward thioredoxin and PDI (requiring glutathione for sustained PDI oxidation); non-catalytic regulatory disulfides have a midpoint reduction potential of approximately −275 mV, making them stable in ER redox conditions and only partially reducible by PDI (E°' ≈ −180 mV), limiting excessive Ero1α activity.\",\n      \"method\": \"In vitro oxidase assay with recombinant Ero1α, site-directed mutagenesis of regulatory cysteines, redox potential measurement\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with recombinant enzyme, mutagenesis, and thermodynamic measurements in one study\",\n      \"pmids\": [\"18971943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CHOP transcriptionally induces Ero1α during ER stress; Ero1α then stimulates the inositol 1,4,5-trisphosphate receptor (IP3R1) to increase IP3-induced calcium release (IICR), promoting calcium-dependent apoptosis. siRNA knockdown of Ero1α or IP3R1 blocks ER stress–induced apoptosis; reconstitution of Ero1α in Chop−/− macrophages restores IICR and apoptosis.\",\n      \"method\": \"siRNA knockdown (Ero1α, IP3R1), genetic loss-of-function (Ero1a, Chop mouse mutants), ectopic reconstitution in Chop−/− macrophages, live-cell calcium imaging, in vivo tunicamycin model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (KO, siRNA, reconstitution), in vitro and in vivo validation, replicated across multiple cell types\",\n      \"pmids\": [\"19752026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Ero1-Lα is transcriptionally induced by hypoxia and hypoglycemia via the HIF-1 transcription factor (independently of p53); siRNA-mediated reduction of Ero1-Lα inhibits VEGF secretion under hypoxia, implicating it as the key adaptive oxidoreductase for disulfide-dependent protein secretion under low-oxygen conditions.\",\n      \"method\": \"HIF-1 genetic epistasis (HIF-1-deficient cells), siRNA knockdown, VEGF secretion assay, diamide rescue experiment, northern/western blotting under hypoxia\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with HIF-1–deficient cells plus siRNA functional readout, two orthogonal approaches in one study\",\n      \"pmids\": [\"15592500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures of human Ero1α in hyperactive and inactive forms reveal that regulatory cysteines are positioned in a flexible loop; disulfide rearrangements within this loop modulate oxidative activity. Specific targeting of PDI is mediated by electrostatic and hydrophobic interactions between the Ero1α protruding β-hairpin and the PDI b'-domain substrate-binding pocket.\",\n      \"method\": \"X-ray crystallography of human Ero1α in two redox states, structural analysis of PDI-interaction interface\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures in two functional states providing atomic-level mechanistic detail\",\n      \"pmids\": [\"20834232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ero1α is almost exclusively localized to the mitochondria-associated ER membrane (MAM); this localization requires oxidizing ER conditions. Chemical reduction of the ER—but not ER stress per se—releases Ero1α from the MAM; normoxic conditions are also required.\",\n      \"method\": \"Subcellular fractionation, confocal immunofluorescence, chemical reduction of ER (DTT), hypoxia experiments\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct fractionation and live-cell imaging with pharmacological manipulation, single lab\",\n      \"pmids\": [\"20186508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ero1α oxidase activity generates H2O2 within the ER lumen in live cells; manipulation of Ero1-Lα levels by overexpression or siRNA causes parallel changes in luminal H2O2. Calcium mobilization from intracellular stores decreases ER H2O2, indicating crosstalk between ER redox and calcium signaling.\",\n      \"method\": \"Live-cell ER-targeted fluorescent H2O2 sensor, Ero1-Lα overexpression and siRNA, calcium mobilization experiments\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — first direct measurement of ER H2O2 in live cells with gain- and loss-of-function validation, novel approach\",\n      \"pmids\": [\"20095866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The Ero1α-PDI redox cycle regulates retro-translocation of cholera toxin CTA1: reduced PDI binds and unfolds CTA1, then Ero1α oxidizes PDI to enable toxin release. Ero1α knockdown increases reduced PDI, blocks toxin release, and increases PDI–Derlin-1 interaction; Ero1α overexpression also blocks retro-translocation by preventing PDI engagement of the toxin.\",\n      \"method\": \"siRNA knockdown, Ero1α overexpression, retro-translocation assay, co-immunoprecipitation of PDI–Derlin-1\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional manipulation (KD and OE) with mechanistic co-IP readout, single lab\",\n      \"pmids\": [\"20130085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ero1α is expressed on blood platelets in association with PDI and αIIbβ3; it is recruited to the platelet surface upon agonist stimulation. Surface Ero1α physically associates with PDI and αIIbβ3 (confirmed by co-immunoprecipitation and confocal colocalization). Blocking surface Ero1α with antibodies decreases platelet aggregation and fibrinogen/PAC-1 binding; Ero1α transfection into MEG01 cells increases αIIbβ3 receptor activity.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy, antibody-blocking platelet aggregation assay, PAC-1/fibrinogen binding, Ero1α transfection in MEG01 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal IP plus functional blocking antibody experiments plus overexpression, single lab\",\n      \"pmids\": [\"20562109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Wild-type Ero1α oxidizes only one PDI active site at a slow rate; a deregulated Ero1α mutant lacking regulatory disulfides oxidizes both PDI active sites equivalently and faster. When PDI active-site cysteines are mutated to lower their reduction potential, wild-type Ero1α oxidizes both sites with a 12-fold increase in rate, demonstrating that PDI reduction potential limits the rate of Ero1α-catalyzed PDI oxidation.\",\n      \"method\": \"Novel dual active-site PDI redox assay, site-directed mutagenesis of Ero1α regulatory cysteines and PDI active sites, in vitro oxidation kinetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis of both enzymes and quantitative kinetic measurements\",\n      \"pmids\": [\"20657012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"After reductive challenge, ER disulfide content recovers within seconds; PDI is the main substrate of Ero1α; Ero1α mixed-disulfide complexes form primarily with PDI and to a lesser extent ERp57 and ERp72, but not with TMX3. PDI oxidation level is precisely regulated, not through ER import/export of thiols but via dynamic equilibrium between Ero1α and glutathione disulfide-mediated oxidation.\",\n      \"method\": \"Kinetics of ER redox recovery (ERO1-deficient cells), mixed-disulfide trapping, redox western blotting of PDI family members, thiol transport experiments\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ERO1-KO cells, disulfide trapping, transport assays) with replicated findings\",\n      \"pmids\": [\"20802462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ero1α is enriched in MAM and regulates Ca2+ fluxes at the ER-mitochondria interface: Ero1α knockdown inhibits mitochondrial Ca2+ fluxes; overexpression of redox-active Ero1α increases passive Ca2+ efflux from the ER, lowering ER Ca2+ content and mitochondrial Ca2+ responses to IP3 agonists.\",\n      \"method\": \"RNA interference, Ero1α overexpression, mitochondrial Ca2+ uniporter activity measurement, live-cell Ca2+ imaging, MAM fractionation\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional genetic manipulation with multiple Ca2+ measurement readouts and MAM localization validation\",\n      \"pmids\": [\"21854214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ERO1α specifically interacts with PDI via its protruding β-hairpin engaging the hydrophobic pocket of the PDI b'-domain, leading to preferential oxidation of the C-terminal PDI a'-domain. ERO1α associates preferentially with reduced PDI. ERp44 inhibits ERO1α-dependent PDI oxidation when an ERp44 mutant lacking the C-terminal tail is used.\",\n      \"method\": \"Docking simulations, systematic biochemical analysis, mixed-disulfide trapping, domain-specific oxidation assays, ERp44 interaction analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural docking combined with biochemical domain dissection and mutagenesis\",\n      \"pmids\": [\"21398518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hyperactive Ero1α (C104A/C131A mutant) leads to hyperoxidation of ERp57 and induces UPR targets BiP and HERP; these effects are mediated through oxidative perturbation of the ER glutathione redox buffer (reversed by NAC, aggravated by BSO). No broad cytosolic antioxidant response is triggered; oxidative challenge is addressed within the ER lumen.\",\n      \"method\": \"Ero1α hyperactive mutant overexpression, microarray transcriptomics, NAC/BSO pharmacological manipulation, cell viability assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — hyperactive mutant plus pharmacological rescue with mechanistic interpretation, single lab\",\n      \"pmids\": [\"23027870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ero1α is identified as interacting with ERp46, ERp57, and P5 (in addition to PDI) by proteomic analysis and surface plasmon resonance; PDI induces conformational flexibility in Ero1α shuttle cysteine Cys99 facilitating intramolecular electron transfer to the active site. PDI preferentially oxidizes other oxidoreductases via its a' domain (bypassing the a domain which accepts electrons from reduced glutathione).\",\n      \"method\": \"Proteomic co-immunoprecipitation of Ero1α-associated proteins, surface plasmon resonance, kinetic measurements, redox equilibrium analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — SPR quantitative binding plus proteomics plus kinetic/redox equilibrium measurements in one study\",\n      \"pmids\": [\"24043701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPx7 utilizes Ero1α-produced H2O2 to promote oxidative protein folding via PDI; H2O2 oxidizes GPx7 Cys57 to sulfenic acid, resolved by Cys86 to form an intramolecular disulfide; both sulfenic acid and disulfide forms of GPx7 can oxidize PDI. GPx7 preferentially interacts with PDI a domain. This Ero1α/GPx7/PDI triad generates two disulfide bonds per O2 consumed.\",\n      \"method\": \"In vitro oxidative folding assay, mutagenesis of GPx7 cysteines, in vivo (cell-based) complementation, interaction domain mapping\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution and mutagenesis plus in vivo validation, mechanistic characterization of entire triad\",\n      \"pmids\": [\"23919619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Ero1α and peroxiredoxin 4 (Prx4) share similar intracellular localization mechanisms in the early secretory compartment: sequential interactions with PDI (preferentially for Ero1α) and ERp44 (equally for both) prevent their secretion in a KDEL/RDEL-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, secretion assays, ER retention competition assays with PDI and ERp44\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical co-IP and functional retention assays, single lab\",\n      \"pmids\": [\"23979138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PDI serves dual roles with Ero1α: either catalytic domain (a or a') rapidly facilitates formation of Ero1α regulatory disulfides (PDI as regulator, independent of substrate-binding domain), while activated Ero1α specifically binds PDI via hydrophobic interactions and preferentially oxidizes domain a' (PDI as substrate). Several PDI family members are potent regulators of Ero1α activity.\",\n      \"method\": \"In vitro oxidase assay, PDI domain mutants, biochemical interaction assays, redox equilibrium analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with domain-specific mutants revealing asymmetric dual regulation mechanism\",\n      \"pmids\": [\"25258311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Specific PDI family members (PDI and ERp46) catalyze the formation of regulatory disulfides in Ero1α to inactivate it; molecular oxygen and H2O2 are inefficient at forming the correct regulatory disulfides. Both active sites of PDI contribute to regulatory disulfide formation in Ero1α, and PDI's substrate-binding domain is required for efficient electron transfer.\",\n      \"method\": \"In vitro regulatory disulfide formation assay under controlled O2, site-directed mutagenesis of PDI active sites, PDI substrate-binding domain mutants\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis establishing a feedback inactivation mechanism\",\n      \"pmids\": [\"24758166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Bisphenol A (BPA) inhibits Ero1α-catalyzed PDI oxidation by blocking the interaction between the PDI b'-domain and the Ero1α β-hairpin; the phenol groups of BPA compete with the conserved tryptophan in Ero1α's protruding β-hairpin for binding to PDI. BPA slows PDI reoxidation and causes PDI reduction in HeLa cells. BPA does not affect the PDI-Prx4 interaction.\",\n      \"method\": \"In vitro Ero1α-PDI oxidation assay with BPA, structural analysis (crystallography of PDI-BPA complex), cell-based PDI redox assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzyme assay with structural validation and cell-based redox confirmation\",\n      \"pmids\": [\"25122773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CHOP promotes hepatocellular injury in acute liver failure through upregulation of ERO1α; CHOP-deficient mice show decreased ERO1α expression and reduced ROS-induced cell death; ERO1α overexpression restores injury in CHOP-deficient mice, demonstrating epistasis: CHOP→ERO1α→ROS.\",\n      \"method\": \"CHOP knockout mouse model, ERO1α overexpression rescue experiment, in vivo ALF model (GalN/LPS), in vitro siRNA\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with KO and reconstitution in vivo, single lab\",\n      \"pmids\": [\"25387528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ERO1-α is required for oxidative folding of MHC class I heavy chains; it associates with PDI, calnexin, and immature MHC class I before peptide-loading complex assembly. ERO1-α regulates the redox state and cell-surface expression of MHC class I, altering susceptibility to CD8+ T cell killing.\",\n      \"method\": \"Co-immunoprecipitation (ERO1α with PDI, calnexin, MHC class I), ERO1α siRNA knockdown, flow cytometry of surface MHC class I, CTL killing assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP establishing complex membership plus functional knockdown with defined immunological readout\",\n      \"pmids\": [\"25870246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cysteines 208 and 241 in Ero1α function beyond negative regulation; their mutation lowers the turnover rate under reducing conditions, identifying a positive catalytic role. A reciprocal crosstalk exists between the stability of the Cys208-Cys241 disulfide and the inhibitory disulfides involving Cys104/Cys131; GPx8 recruitment to Ero1α is controlled by the Cys208/Cys241 redox state.\",\n      \"method\": \"Site-directed mutagenesis, in vitro oxidase activity assays, reductive stimulation experiments, GPx8 co-immunoprecipitation\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzyme mutagenesis with mechanistic interpretation, single lab\",\n      \"pmids\": [\"26609561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The Cys208-Cys241 disulfide in Ero1α is reduced by PDI and other PDI family members during PDI oxidation; this disulfide pair provides a platform for functional interaction with PDI that enhances Ero1α oxidative activity. Mutation of Cys208/Cys241 does not affect overall Ero1α structure (confirmed by DSC and SAXS), establishing a purely functional regulatory role for this pair.\",\n      \"method\": \"In vitro PDI oxidation assay, differential scanning calorimetry (DSC), small-angle X-ray scattering (SAXS), site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with structural validation (DSC and SAXS) plus mutagenesis\",\n      \"pmids\": [\"27703014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ERO1-α promotes production of PD-L1 in breast cancer cells via two mechanisms: facilitating oxidative folding of PD-L1 protein and increasing HIF-1α protein expression, which in turn elevates PD-L1 mRNA; ERO1-α depletion reduces tumor PD-L1 and inhibits Jurkat T cell apoptosis induced by tumor PD-L1.\",\n      \"method\": \"ERO1-α siRNA/overexpression, PD-L1 flow cytometry, HIF-1α western blotting, Jurkat co-culture apoptosis assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional manipulation with protein folding and signaling readouts, single lab\",\n      \"pmids\": [\"28160557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ERO1α KO by CRISPR/Cas9 in HCT116 colorectal cancer cells changes integrin-β1 glycosylation, reduces cell-surface integrin-β1 expression specifically under hypoxia, and results in contact-inhibited morphology and diminished cell motility. This establishes a link between ERO1α expression and integrin-β1 activation under hypoxic conditions.\",\n      \"method\": \"CRISPR/Cas9 knockout, glycosylation analysis, flow cytometry of surface integrin-β1, cell motility and proliferation assays under normoxia/hypoxia\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined glycoprotein and cell biological phenotype, single lab\",\n      \"pmids\": [\"28839225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TAM-secreted CCL2 induces ERO1-α upregulation in non-neoplastic MCF10A breast epithelial cells; ERO1-α is required for TAM-induced MMP-9 upregulation and invasive phenotype involving transcription factors c-Fos and c-Jun.\",\n      \"method\": \"Indirect co-culture system, comparative proteomics, ERO1-α siRNA, cytokine array, MMP-9 assay, invasion assay\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics identification plus siRNA functional validation with defined signaling readout\",\n      \"pmids\": [\"30165193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Fam20C (Golgi casein kinase) phosphorylates Ero1α at Ser145, greatly enhancing its oxidase activity. This phosphorylation occurs in the Golgi and Ero1α is then retrograde-transported to the ER via ERp44. Fam20C depletion results in a more reduced ER; phosphorylation is induced under hypoxia, reductive stress, and lactation.\",\n      \"method\": \"Co-immunoprecipitation of Fam20C with ER luminal proteins, in vitro kinase assay, Ser145 phospho-mutants, ER redox assay, MS phosphorylation site identification, ERp44 dependence assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus site identification by MS plus functional phospho-mutants plus cell-based ER redox readout\",\n      \"pmids\": [\"29858230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FBXO6, a substrate recognition component of the SCF E3 ubiquitin ligase, mediates polyubiquitination and proteasomal degradation of the N-glycoprotein Ero1L; FBXO6 overexpression increases Ero1L polyubiquitination and decreases its stability, while FBXO6 inhibition prolongs Ero1L half-life.\",\n      \"method\": \"Co-immunoprecipitation, in vivo ubiquitination assay, Ero1L stability/half-life assay, FBXO6 overexpression/knockdown\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ubiquitination assay plus stability assay, single lab\",\n      \"pmids\": [\"27855403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Ero1α-mediated SR oxidation causes dissociation of intraluminal ERp44 from the RyR2 Ca2+ channel via a redox-sensitive interaction involving RyR2 Cys4806; Ero1α inhibition (EN460) or genetic knockdown normalizes SR redox, restores ERp44-RyR2 association, increases Ca2+ transient amplitude, and reduces proarrhythmic spontaneous Ca2+ waves in hypertrophic cardiomyocytes.\",\n      \"method\": \"Pharmacological inhibition (EN460), Ero1α overexpression, site-directed mutagenesis of RyR2-Cys4806, molecular dynamics simulation, Ca2+ imaging, ERroGFP SR redox biosensor, animal model (TAB)\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis identifying specific cysteine, molecular dynamics, live SR redox sensor, and animal disease model, multiple orthogonal methods\",\n      \"pmids\": [\"35086342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Ero1α S-nitrosation by inducible nitric oxide synthase (iNOS) decreases its oxidase activity, causing ER reductive stress during replicative senescence. Inhibition of iNOS decreases Ero1α S-nitrosation and senescence; expression of constitutively active Ero1α restores ER oxidizing state and rescues senescent phenotypes.\",\n      \"method\": \"ER-specific fluorescent redox probes (glutathione and H2O2 sensors), ER-specific catalase model, Ero1α S-nitrosation detection, iNOS inhibition, constitutively active Ero1α overexpression\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PTM identification (S-nitrosation) with functional rescue by constitutively active Ero1α, single lab\",\n      \"pmids\": [\"35033630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"On the platelet surface, Ero1α constitutively oxidizes PDI and further regulates platelet aggregation in a glutathione-dependent manner; the Ero1α/PDI system oxidizes GSH and establishes the reduction potential optimal for platelet aggregation. Oxidized (not reduced) PDI promotes platelet aggregation.\",\n      \"method\": \"Platelet redox assay, Ero1α inhibitor (EN460), PDI redox state measurement, glutathione manipulation, platelet aggregation assay\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical demonstration of extracellular Ero1α/PDI/GSH electron transport with functional aggregation readout, single lab\",\n      \"pmids\": [\"35077997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ERO1 deficiency retards disulfide bond formation in VEGF121 and increases utilization of its single N-glycosylation sequon; ERO1-KO cells show increased interaction of VEGF121 with N-glycosylation pathway proteins, particularly MAGT1 (a thioredoxin-containing component of the post-translational OST complex). ERO1 is thus a physiologic regulator of protein N-glycosylation.\",\n      \"method\": \"ERO1-KO cells, mass spectrometry (unbiased interaction proteomics), N-glycosylation assay, VEGF121 secretion assay\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO cells with unbiased MS interactomics and defined glycoprotein readout, single lab\",\n      \"pmids\": [\"36063727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SUMOylation of ERp44 at Lys76 by Ubc9 enhances its covalent binding to Ero1α and ER retention; loss of ERp44 SUMOylation promotes ERp44 degradation and Ero1α secretion, thereby reducing ER stress.\",\n      \"method\": \"Adipocyte-specific Ubc9 KO mice, LC-MS identification of SUMOylated ERp44, K76 mutation, ERp44-Ero1α co-immunoprecipitation, Ero1α secretion assay\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-identified SUMOylation site with functional co-IP and in vivo KO model, single lab\",\n      \"pmids\": [\"36427672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ERO1A ablation in tumor cells impairs the balance between IRE1α and PERK signaling, induces lethal unfolded protein responses, and promotes immunogenic cell death, enhancing anti-tumor T cell immunity and the efficacy of anti-PD-1 therapy.\",\n      \"method\": \"ERO1A genetic ablation in tumor cells, single-cell RNA-sequencing of tumor microenvironment, UPR pathway analysis, immunogenic cell death assay, anti-PD-1 therapeutic models\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic ablation with scRNA-seq and mechanistic UPR pathway analysis, single lab\",\n      \"pmids\": [\"37769655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Platelet ERO1α localizes exclusively in the dense tubular system and promotes Ca2+ mobilization, platelet activation, and aggregation by directly interacting with STIM1 and SERCA2, modifying an allosteric Cys49-Cys56 disulfide in STIM1 and a Cys875-Cys887 disulfide in SERCA2. Mutant STIM1-Cys49/56Ser and SERCA2-Cys875/887Ser show impaired ERO1α interactions.\",\n      \"method\": \"Megakaryocyte-specific and global Ero1α KO mice, intravital microscopy, mass spectrometry, electron microscopy, site-directed mutagenesis of STIM1 and SERCA2 cysteines, Ca2+ mobilization assay, biochemical co-IP\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic KO with MS identification plus site-directed mutagenesis of substrate cysteines plus multiple functional readouts in vivo and in vitro\",\n      \"pmids\": [\"37132383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ERO1A is a functional downstream target of mTORC1; elevated ERO1α promotes ferroptosis resistance via upregulation of SLC7A11 through activation of the IL-6/STAT3 signaling pathway; ERO1α stimulates SLC7A11 transcription via IL-6/STAT3-mediated promoter activation.\",\n      \"method\": \"mTORC1-activated cell models, RNA-seq, cytokine array, ELISA, luciferase reporter assay, chromatin immunoprecipitation, in vivo xenograft and patient-derived xenograft models\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase reporter establishing transcriptional mechanism plus in vivo validation, single lab\",\n      \"pmids\": [\"38610018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ERO1A interacts with SEPN1 (selenoprotein N) at the MAM; ERO1A depletion in SEPN1 KO cells restores ER redox, re-equilibrates MAM contacts, and rescues mitochondrial bioenergetics and diaphragmatic weakness. ERO1A KO in a SEPN1-loss mouse background blunts ER stress and improves MAM Ca2+ levels and bioenergetics.\",\n      \"method\": \"Co-immunoprecipitation (ERO1A-SEPN1), ERO1A KO in SEPN1-KO mouse model, ER redox assay, MAM fractionation, Ca2+ measurements, respiratory chain assay, diaphragm contractility assay\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct interaction demonstrated by co-IP, functional double-KO rescue in vivo across multiple readouts\",\n      \"pmids\": [\"38402623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Specific deletion of ERO1-1α (but not ERO-1β) significantly attenuates palmitate-induced oxidative ER stress, ER Ca2+ dysregulation, mitochondrial H2O2 accumulation, and β-cell death; overexpression of redox-active ERO-1α has the opposite proapoptotic effect.\",\n      \"method\": \"ERO-1α-specific knockout (CRISPR), ERO-1α overexpression, ER-targeted H2O2 and redox sensors, mitochondrial membrane potential assay, Ca2+ imaging, insulin secretion assay\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific KO and OE with multiple compartment-specific readouts, single lab\",\n      \"pmids\": [\"38692092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SIRT5 desuccinylates ERO1A at Lys396; under simulated microgravity, SIRT5 is downregulated and ERO1A Lys396 succinylation increases, promoting vascular endothelial cell apoptosis. SIRT5 overexpression protects HUVECs from apoptosis and knockdown of SIRT5 induces apoptosis through ERO1A Lys396 succinylation.\",\n      \"method\": \"LC-MS/MS quantitative succinylome, immunoprecipitation-western blot for Lys396 succinylation, SIRT5 overexpression/knockdown, HUVEC apoptosis assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS site identification plus gain/loss-of-function with defined apoptosis readout, single lab\",\n      \"pmids\": [\"40243486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"METTL3-mediated m6A modification of ERO1A mRNA negatively regulates its expression in trophoblasts; METTL3 knockdown elevates ERO1A expression via m6A-dependent mechanism and promotes trophoblast migration and invasion; ERO1A inhibition diminishes the pro-migratory effect of METTL3 depletion.\",\n      \"method\": \"MeRIP-qPCR (m6A-IP), METTL3 knockdown/overexpression, ERO1A functional rescue, trophoblast migration/invasion assays\",\n      \"journal\": \"Placenta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MeRIP-qPCR establishing m6A modification of specific transcript plus epistatic rescue experiment, single lab\",\n      \"pmids\": [\"40652673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ERO1L-mediated ROS generation is essential for its oncogenic activities in pancreatic cancer; an inactive mutant (ERO1-C394A) fails to promote tumor growth, demonstrating catalytic activity requirement. ERO1L regulates the Warburg effect and aerobic glycolysis, with glycolysis inhibition partially abrogating its growth-promoting activity.\",\n      \"method\": \"ERO1L wild-type vs C394A inactive mutant overexpression, EN460 inhibitor, in vitro proliferation and in vivo xenograft assays, glycolysis inhibitor rescue\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — active-site mutant comparison with functional readout, single lab\",\n      \"pmids\": [\"32724477\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ERO1A is an ER-localized flavoenzyme (FAD-dependent) that acts as the primary sulfhydryl oxidase for oxidative protein folding: it transfers oxidizing equivalents to PDI via a cyclic disulfide relay involving two conserved cysteine triads (Cys94/99 active site and Cys394/397 outer active site) and a flexible regulatory loop (Cys104/131 and Cys208/241), generating H2O2 as a byproduct; its activity is tightly regulated through intramolecular regulatory disulfide switches and a feedback loop in which reduced PDI activates—and oxidized PDI inactivates—the enzyme. Ero1α is enriched in the MAM subdomain of the ER, where it regulates Ca2+ fluxes toward mitochondria via IP3R (regulated by CHOP-dependent induction under ER stress) and RyR2 (via ERp44 dissociation). Ero1α is retained in the ER by dynamic covalent interactions with ERp44 and non-covalent interactions with PDI, and is regulated post-translationally by Fam20C phosphorylation (Ser145, activating), FBXO6-mediated ubiquitination and degradation, iNOS-mediated S-nitrosation (inactivating), and SIRT5-regulated succinylation at Lys396. On platelets, extracellular Ero1α oxidizes PDI and modifies disulfide bonds in STIM1 (Cys49-Cys56) and SERCA2 (Cys875-Cys887) to promote Ca2+ mobilization and aggregation. In cancer and hypoxia, Ero1α is transcriptionally induced by HIF-1α and CHOP to support secretion of disulfide-rich proteins (VEGFA, PD-L1, MHC class I, adiponectin) and to drive pro-tumorigenic signaling including the IL-6/STAT3/SLC7A11 axis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ERO1A (Ero1\\u03b1) is a FAD-dependent, ER-resident type II membrane sulfhydryl oxidase that serves as a primary engine of oxidative protein folding by feeding oxidizing equivalents into protein disulfide isomerase (PDI) [#0, #15]. It catalyzes disulfide bond formation through a cyclic relay involving two conserved cysteine triads (the Cys85-Cys94-Cys99 active site and the Cys391-Cys394-Cys397 outer site), with Cys94 forming the mixed disulfide that transfers oxidizing power to PDI; mutation of Cys394 or Cys397 abolishes activity [#0, #1]. Specific targeting of PDI is achieved through a protruding \\u03b2-hairpin that docks into the hydrophobic pocket of the PDI b'-domain, directing preferential oxidation of the PDI a' active site [#9, #17]. Ero1\\u03b1 activity is tightly self-limiting: regulatory disulfides in a flexible loop (involving Cys104/Cys131 and Cys208/Cys241) toggle the enzyme between active and inactive states, and reduced PDI activates while oxidized PDI inactivates the oxidase, creating a feedback loop that matches output to substrate demand [#4, #6, #9, #23, #28]. Because the catalytic cycle consumes O2 and generates H2O2, Ero1\\u03b1 is a major source of luminal ER H2O2, which is productively re-used by peroxidases such as GPx7 to drive further PDI oxidation [#11, #20]. The enzyme is dynamically retained in the early secretory pathway through covalent binding to ERp44 and non-covalent association with PDI, which also chaperones it against aggregation [#2, #21]. Layered post-translational controls tune its activity and abundance: Fam20C phosphorylation at Ser145 activates the oxidase, FBXO6-directed ubiquitination drives its proteasomal degradation, ERp44 SUMOylation governs its ER retention versus secretion, iNOS-mediated S-nitrosation inactivates it, and SIRT5-reversed Lys396 succinylation modulates its pro-apoptotic activity [#32, #33, #38, #35, #44]. Functionally, Ero1\\u03b1 supports secretion and folding of disulfide-rich clients including adiponectin, VEGF, MHC class I, PD-L1 and Notch [#3, #8, #26, #29, #5], and it is enriched at the mitochondria-associated ER membrane where it shapes Ca2+ fluxes toward mitochondria and is wired into ER-stress apoptosis via CHOP-dependent induction and IP3R1 stimulation [#10, #16, #7]. On the platelet surface and dense tubular system, extracellular Ero1\\u03b1 oxidizes PDI and modifies allosteric disulfides in STIM1 (Cys49-Cys56) and SERCA2 (Cys875-Cys887) to promote Ca2+ mobilization and aggregation [#13, #36, #40]. In cancer and hypoxia, HIF-1\\u03b1- and CHOP-driven Ero1\\u03b1 supports tumor secretion and pro-tumorigenic signaling, including an mTORC1\\u2192Ero1\\u03b1\\u2192IL-6/STAT3/SLC7A11 axis conferring ferroptosis resistance, in a manner dependent on its catalytic activity [#8, #41, #46].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that the human ERO1 ortholog is a functional ER oxidoreductase, answering whether the yeast oxidative-folding machinery is conserved in mammals.\",\n      \"evidence\": \"Yeast ero1-1 complementation, microsome fractionation, Endo-H glycan analysis and cysteine mutagenesis\",\n      \"pmids\": [\"10671517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the full disulfide relay to PDI\", \"Cofactor and partner enzymes not yet mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the dual cysteine-triad electron-transfer architecture and identified PDI and ERp44 as mixed-disulfide partners, establishing how oxidizing equivalents move through the enzyme.\",\n      \"evidence\": \"Yeast complementation, mutagenesis and mixed-disulfide trapping with PDI/ERp44\",\n      \"pmids\": [\"15136577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-level interface with PDI not resolved\", \"Regulatory disulfide switch not yet defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected Ero1\\u03b1 to physiological hypoxic adaptation by showing HIF-1-dependent induction supports secretion of disulfide-rich VEGF, framing it as the adaptive oxidoreductase under low oxygen.\",\n      \"evidence\": \"HIF-1-deficient cell epistasis, siRNA knockdown and VEGF secretion assay under hypoxia\",\n      \"pmids\": [\"15592500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address other hypoxic clients\", \"Mechanism of catalysis under low O2 not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved how a soluble-pathway oxidase is kept in the ER, showing competing covalent ERp44 and non-covalent PDI interactions retain and chaperone Ero1\\u03b1.\",\n      \"evidence\": \"Secretion/retention assays and co-IP in HeLa with dominant-negative PDI mutants\",\n      \"pmids\": [\"16677073\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative affinities not determined\", \"How retention is dynamically modulated not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Uncovered the intramolecular disulfide switch and substrate-feedback logic that prevents hyperoxidation, answering how the enzyme avoids runaway activity.\",\n      \"evidence\": \"MS identification of a Cys94-Cys131 regulatory disulfide, cell-based oxidation assays, mutants, isoform comparison, plus in vitro redox potential measurements; and in vivo demonstration that CHOP induces Ero1\\u03b1 to stimulate IP3R1-mediated Ca2+ apoptosis and that Ero1\\u03b1 oxidizes Notch LNR disulfides in Drosophila\",\n      \"pmids\": [\"18833192\", \"18971943\", \"19752026\", \"18809725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of loop rearrangement not yet visualized\", \"Full roster of regulatory cysteines incomplete\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided atomic and quantitative mechanism: crystal structures in two redox states plus kinetic assays showed PDI reduction potential and loop disulfides set the rate of catalysis, and localization/imaging tied Ero1\\u03b1 to the MAM, luminal H2O2 production, and ER-mitochondria Ca2+ fluxes.\",\n      \"evidence\": \"X-ray crystallography, dual active-site PDI redox kinetics, ER-targeted H2O2 sensor, MAM fractionation and Ca2+ imaging, plus platelet-surface co-IP and aggregation assays\",\n      \"pmids\": [\"20834232\", \"20657012\", \"20095866\", \"20186508\", \"21854214\", \"20802462\", \"20130085\", \"20562109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of MAM enrichment not fully tested\", \"Identity of all MAM Ca2+ effectors incomplete\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Expanded the oxidoreductase network and refined how PDI both regulates and is a substrate, showing Ero1\\u03b1 partners with multiple PDI-family members and forms a peroxidase relay with GPx7 that reuses H2O2.\",\n      \"evidence\": \"Proteomic co-IP, SPR, in vitro folding assays with GPx7 cysteine mutants and domain mapping\",\n      \"pmids\": [\"24043701\", \"23919619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative flux through PDI vs GPx7/GSH routes in vivo unquantified\", \"Selectivity among PDI-family partners not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dissected the asymmetric dual role of PDI as both regulator and substrate and identified small-molecule (BPA) interference, clarifying the feedback inactivation logic.\",\n      \"evidence\": \"In vitro oxidase assays with PDI domain mutants, regulatory disulfide formation under controlled O2, and structural/cell-based analysis of BPA inhibition\",\n      \"pmids\": [\"25258311\", \"24758166\", \"25122773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular concentrations driving regulator vs substrate modes unknown\", \"Physiological relevance of BPA exposure not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Refined the regulatory cysteine map by assigning a positive catalytic and PDI-interaction role to Cys208/Cys241, and extended client/disease scope to MHC class I folding and CHOP-driven liver injury.\",\n      \"evidence\": \"Mutagenesis with in vitro oxidase assays and GPx8 co-IP; co-IP/knockdown for MHC class I; CHOP-KO mouse with Ero1\\u03b1 rescue in acute liver failure\",\n      \"pmids\": [\"26609561\", \"25870246\", \"25387528\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural impact of Cys208/Cys241 minimal but functional role mechanism partial\", \"MHC class I and liver findings from single labs\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified post-translational activation by Fam20C phosphorylation and degradation by FBXO6, establishing kinase- and ubiquitin-based control over Ero1\\u03b1 levels and activity.\",\n      \"evidence\": \"In vitro kinase assay with MS site mapping and phospho-mutants; in vivo ubiquitination and half-life assays; plus TAM/CCL2-induced upregulation driving invasion\",\n      \"pmids\": [\"29858230\", \"27855403\", \"30165193\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Crosstalk between phosphorylation, degradation and redox switches unresolved\", \"Upstream signals coordinating these PTMs incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established Ero1\\u03b1 as a redox node controlling Ca2+ handling in distinct tissues and as a target of multiple PTMs, by identifying its substrate cysteines on RyR2 and its inactivation by S-nitrosation and its ERp44-SUMO-controlled retention.\",\n      \"evidence\": \"RyR2-Cys4806 mutagenesis with SR redox biosensor and animal model; iNOS S-nitrosation with constitutively active Ero1\\u03b1 rescue; ERp44 SUMOylation co-IP with Ubc9-KO mice; platelet GSH redox assays; ERO1-KO interactomics linking it to N-glycosylation via MAGT1\",\n      \"pmids\": [\"35086342\", \"35033630\", \"36427672\", \"35077997\", \"36063727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of these PTMs into a single regulatory hierarchy unclear\", \"Tissue specificity of substrate disulfide modification not generalized\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected Ero1\\u03b1 to UPR balance and tumor immunity, showing its ablation skews IRE1\\u03b1/PERK signaling toward immunogenic cell death and enhances anti-PD-1 efficacy.\",\n      \"evidence\": \"Genetic ablation in tumor cells with scRNA-seq, UPR analysis and anti-PD-1 therapeutic models\",\n      \"pmids\": [\"37769655\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular link between Ero1\\u03b1 loss and UPR branch imbalance not mapped\", \"Single-lab tumor models\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed Ero1\\u03b1 downstream of mTORC1 in cancer metabolism and within MAM/muscle physiology, defining an IL-6/STAT3/SLC7A11 ferroptosis-resistance axis and a SEPN1 interaction governing ER redox and bioenergetics.\",\n      \"evidence\": \"mTORC1 cell models with ChIP and luciferase reporter plus xenografts; ERO1A-SEPN1 co-IP with double-KO mouse rescue; isoform-specific KO in palmitate-stressed \\u03b2-cells\",\n      \"pmids\": [\"38610018\", \"38402623\", \"38692092\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which mTORC1 elevates Ero1\\u03b1 not fully defined\", \"Single-lab disease models\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended PTM regulation to SIRT5-reversed Lys396 succinylation and m6A-based mRNA control, linking Ero1\\u03b1 to endothelial apoptosis and trophoblast invasion.\",\n      \"evidence\": \"Quantitative succinylome/MS with SIRT5 gain/loss in HUVECs; MeRIP-qPCR with METTL3 manipulation and ERO1A rescue in trophoblasts\",\n      \"pmids\": [\"40243486\", \"40652673\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Effect of Lys396 succinylation on catalytic mechanism not biochemically resolved\", \"Single-lab, context-specific findings\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many layers of regulation (intramolecular disulfide switches, phosphorylation, ubiquitination, S-nitrosation, succinylation, SUMO-controlled retention, m6A) are integrated to set Ero1\\u03b1 activity in specific cell types and disease states remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking PTM hierarchy to redox switching\", \"In vivo flux balance between Ero1\\u03b1, GPx7/8, Prx4 and glutathione routes unquantified\", \"Therapeutic consequences of selective Ero1\\u03b1 inhibition across tissues untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 6, 14, 46]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [15, 17, 40]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 2, 11]},\n      {\"term_id\": \"GO:0005789\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13, 36, 40]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 15, 20]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [7, 8, 39]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [13, 36, 40]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"P4HB\", \"ERp44\", \"ERp46\", \"ERp57\", \"GPX7\", \"GPX8\", \"STIM1\", \"ATP2A2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":10,"faith_total":10,"faith_pct":100.0}}